<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:45:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9369243" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9369243</identifier>
        <datestamp>2022-08-12</datestamp>
        <setSpec>ijms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="review-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">ijms</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Molecular Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1422-0067</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9369243</article-id>
              <article-id pub-id-type="pmcid">PMC9369243</article-id>
              <article-id pub-id-type="pmc-uid">9369243</article-id>
              <article-id pub-id-type="pmid">35955775</article-id>
              <article-id pub-id-type="doi">10.3390/ijms23158650</article-id>
              <article-id pub-id-type="publisher-id">ijms-23-08650</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Review</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Microgravity-Related Changes in Bone Density and Treatment Options: A Systematic Review</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4298-6811</contrib-id>
                  <name>
                    <surname>Baran</surname>
                    <given-names>Ronni</given-names>
                  </name>
                  <xref rid="af1-ijms-23-08650" ref-type="aff">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8160-859X</contrib-id>
                  <name>
                    <surname>Wehland</surname>
                    <given-names>Markus</given-names>
                  </name>
                  <xref rid="af2-ijms-23-08650" ref-type="aff">2</xref>
                  <xref rid="af3-ijms-23-08650" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schulz</surname>
                    <given-names>Herbert</given-names>
                  </name>
                  <xref rid="af2-ijms-23-08650" ref-type="aff">2</xref>
                  <xref rid="af3-ijms-23-08650" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Heer</surname>
                    <given-names>Martina</given-names>
                  </name>
                  <xref rid="af4-ijms-23-08650" ref-type="aff">4</xref>
                  <xref rid="af5-ijms-23-08650" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Infanger</surname>
                    <given-names>Manfred</given-names>
                  </name>
                  <xref rid="af2-ijms-23-08650" ref-type="aff">2</xref>
                  <xref rid="af3-ijms-23-08650" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4991-3105</contrib-id>
                  <name>
                    <surname>Grimm</surname>
                    <given-names>Daniela</given-names>
                  </name>
                  <xref rid="af1-ijms-23-08650" ref-type="aff">1</xref>
                  <xref rid="af2-ijms-23-08650" ref-type="aff">2</xref>
                  <xref rid="af3-ijms-23-08650" ref-type="aff">3</xref>
                  <xref rid="c1-ijms-23-08650" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Kim</surname>
                    <given-names>Jung Eun</given-names>
                  </name>
                  <role>Academic Editor</role>
                </contrib>
              </contrib-group>
              <aff id="af1-ijms-23-08650"><label>1</label>Department of Biomedicine, Aarhus University, Ole Worms Allé 4, 8000 Aarhus, Denmark; <email>201709730@post.au.dk</email></aff>
              <aff id="af2-ijms-23-08650"><label>2</label>Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany; <email>markus.wehland@med.ovgu.de</email> (M.W.); <email>herbert.schulz@med.ovgu.de</email> (H.S.); <email>manfred.infanger@med.ovgu.de</email> (M.I.)</aff>
              <aff id="af3-ijms-23-08650"><label>3</label>Research Group ‘Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen’ (MARS), Otto von Guericke University, Universitätsplatz 2, 39106 Magdeburg, Germany</aff>
              <aff id="af4-ijms-23-08650"><label>4</label>IU International University of Applied Sciences, 99084 Erfurt, Germany; <email>martina.heer@iu.org</email></aff>
              <aff id="af5-ijms-23-08650"><label>5</label>Institute of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, 53115 Bonn, Germany</aff>
              <author-notes>
                <corresp id="c1-ijms-23-08650"><label>*</label>Correspondence: <email>daniela.grimm@med.ovgu.de</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>03</day>
                <month>8</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2022</year>
              </pub-date>
              <volume>23</volume>
              <issue>15</issue>
              <elocation-id>8650</elocation-id>
              <history>
                <date date-type="received">
                  <day>30</day>
                  <month>6</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>8</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 by the authors.</copyright-statement>
                <copyright-year>2022</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Space travelers are exposed to microgravity (µ<italic toggle="yes">g</italic>), which induces enhanced bone loss compared to the age-related bone loss on Earth. Microgravity promotes an increased bone turnover, and this obstructs space exploration. This bone loss can be slowed down by exercise on treadmills or resistive apparatus. The objective of this systematic review is to provide a current overview of the state of the art of the field of bone loss in space and possible treatment options thereof. A total of 482 unique studies were searched through PubMed and Scopus, and 37 studies met the eligibility criteria. The studies showed that, despite increased bone formation during µ<italic toggle="yes">g</italic>, the increase in bone resorption was greater. Different types of exercise and pharmacological treatments with bisphosphonates, RANKL antibody (receptor activator of nuclear factor κβ ligand antibody), proteasome inhibitor, pan-caspase inhibitor, and interleukin-6 monoclonal antibody decrease bone resorption and promote bone formation. Additionally, recombinant irisin, cell-free fat extract, cyclic mechanical stretch-treated bone mesenchymal stem cell-derived exosomes, and strontium-containing hydroxyapatite nanoparticles also show some positive effects on bone loss.</p>
              </abstract>
              <kwd-group>
                <kwd>spaceflight</kwd>
                <kwd>microgravity</kwd>
                <kwd>astronauts</kwd>
                <kwd>cells</kwd>
                <kwd>animals</kwd>
                <kwd>bone loss</kwd>
                <kwd>signaling pathways</kwd>
                <kwd>countermeasures</kwd>
                <kwd>pharmacology</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>Deutsches Zentrum für Luft und Raumfahrt (DLR)</funding-source>
                </award-group>
                <award-group>
                  <funding-source>BMWi projects</funding-source>
                  <award-id>50WB1924</award-id>
                  <award-id>50WB2219</award-id>
                </award-group>
                <funding-statement>This research was funded by the Deutsches Zentrum für Luft und Raumfahrt (DLR), BMWi projects 50WB1924 (DG) and 50WB2219 (DG).</funding-statement>
              </funding-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-ijms-23-08650">
              <title>1. Introduction</title>
              <p>The length of a space mission and, thus, the amount of time space pilots are spending in orbit have been increased since humans have started conquering space. Space travelers are affected by numerous stressors in space, which include psychological factors such as isolation, psychosocial factors such as family disruption, human factors such as food restrictions, habitability factors such as lack of privacy, and physical factors such as radiation and microgravity (µ<italic toggle="yes">g</italic>) [<xref rid="B1-ijms-23-08650" ref-type="bibr">1</xref>,<xref rid="B2-ijms-23-08650" ref-type="bibr">2</xref>].</p>
              <p>Microgravity is known to induce changes and health problems in the human body, such as cardiovascular, immune, or musculoskeletal health concerns [<xref rid="B3-ijms-23-08650" ref-type="bibr">3</xref>,<xref rid="B4-ijms-23-08650" ref-type="bibr">4</xref>,<xref rid="B5-ijms-23-08650" ref-type="bibr">5</xref>]. One of the reasons for the problems in the musculoskeletal system is mechanical unloading caused by µ<italic toggle="yes">g</italic>. In addition, µ<italic toggle="yes">g</italic> leads to skeletal muscle atrophy and bone loss (BL), among other effects. BL can be seen as a reduction in bone mineral density (BMD). The µ<italic toggle="yes">g</italic>-induced reduction in BMD occurs at a fast rate of 0.5–1.5% per month in space [<xref rid="B5-ijms-23-08650" ref-type="bibr">5</xref>,<xref rid="B6-ijms-23-08650" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-08650" ref-type="bibr">7</xref>].</p>
              <p>Therefore, a systematic review was conducted to investigate to what extent this phenomenon resembles postmenopausal (PMP) osteoporosis (OP) on Earth, keeping in mind that the main cause/mechanism of postmenopausal osteoporosis is different from the reduction in BMD in µ<italic toggle="yes">g</italic>. For this purpose, recent findings on the mechanisms of µ<italic toggle="yes">g</italic>-related changes in bone density and possible treatment options are discussed. Furthermore, clinical trials are presented to complement in vitro with in vivo data. Overall, this review provides a current overview of the state of the art of the field of BL in space and also discusses possible implications for OP patients on Earth.</p>
              <sec id="sec1dot1-ijms-23-08650">
                <title>1.1. Postmenopausal Osteoporosis</title>
                <p>The OP diagnostic criterion is a T-score ≤ −2.5 standard deviation below the mean for young healthy adults at the femoral neck, lumbar spine, or total hip by BMD testing [<xref rid="B8-ijms-23-08650" ref-type="bibr">8</xref>,<xref rid="B9-ijms-23-08650" ref-type="bibr">9</xref>,<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>]. PMP OP is known as primary OP type I and is caused most likely by reduced estrogen levels, which eventually lead to increased bone resorption (BRS) [<xref rid="B8-ijms-23-08650" ref-type="bibr">8</xref>]. The bone mass reaches its maximum, named the peak bone mass, at the end of the bone maturation process around the age of 28–30 years. It is particularly dependent on a sufficient calcium intake, adequate vitamin D intake, genetics, and physical activity [<xref rid="B11-ijms-23-08650" ref-type="bibr">11</xref>,<xref rid="B12-ijms-23-08650" ref-type="bibr">12</xref>,<xref rid="B13-ijms-23-08650" ref-type="bibr">13</xref>].</p>
                <p>The increased BRS is closely related to hormonal changes, especially to the decline in the endogenous estrogen production at menopause. Estrogen has an inhibitory effect on osteoclasts (OCs); therefore, the deprivation of estrogen is associated with the loss of BMD. Deprivation of estrogen also contributes to increased urinary calcium loss and reduced intestinal calcium absorption, which is caused by calcium influx from the estrogen-deprived bones into the plasma and eventually results in reduced levels of parathyroid hormone (PTH) [<xref rid="B14-ijms-23-08650" ref-type="bibr">14</xref>,<xref rid="B15-ijms-23-08650" ref-type="bibr">15</xref>].</p>
                <p>Following the European guidelines and the guidelines of the American Association of Clinical Endocrinologists (AACE), the treatment of OP can be divided into nonpharmacological and pharmacological strategies. The nonpharmacological strategy consists of lowering the risk of falling and optimizing the dietary intake. The risk of falling is lowered by physical exercise, reduction in consumption of alertness- and balance-altering medication, and home environment improvement, among others, while optimizing the dietary intake is achieved by ensuring that the patient consumes enough protein and calories, as well as calcium and vitamin D, which can be achieved with supplements [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>]. A diet with high potential renal acid load might also increase urinary calcium excretion, and a diet high in alkaline precursors might reduce urinary calcium excretion (uCaV) and urinary N-telopeptide (uNTx), while increasing femoral neck, lumbar spine, and total hip BMD. In spaceflight, the effect depends very much on the exercise level/mechanical loading [<xref rid="B17-ijms-23-08650" ref-type="bibr">17</xref>,<xref rid="B18-ijms-23-08650" ref-type="bibr">18</xref>].</p>
                <p>Pharmacological treatment can be divided into antiresorptive (bisphosphonate (BP)), receptor activator of nuclear factor κβ ligand (RANKL) antibody, selective estrogen receptor modulator (SERM), antisclerostin antibody, and anabolic medication (see <xref rid="ijms-23-08650-f001" ref-type="fig">Figure 1</xref>) [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>,<xref rid="B19-ijms-23-08650" ref-type="bibr">19</xref>].</p>
                <p>SERMs, such as raloxifene, reduce BL by binding to the estrogen receptor, where they act as an estrogen agonist or antagonist, depending on the tissue. BPs, such as alendronate, reduce BL by reducing OC recruitment and activity and increasing the apoptosis of OCs. RANKL antibodies, such as denosumab, reduce BL by binding to RANKL, which prevents OC activation. Teriparatide is an anabolic medication. It is the 1–34 N-terminal fragment of PTH; it induces bone formation (BF) and improves the skeletal architecture by increasing the activity and number of osteoblasts (OBs) [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>].</p>
                <p>Sclerostin, synthesized in osteocytes, inhibits bone formation. It is responsible to keep the balance between new bone tissue formation and resorption of old bone tissue. It exerts antianabolic effects on bone. The protein sclerostin binds to LRP5/6 receptors and inhibits wingless-related integration site (Wnt) signaling, which results in a reduction in bone formation [<xref rid="B20-ijms-23-08650" ref-type="bibr">20</xref>]. Targeting sclerostin is important because of the protein’s special antianabolic action on bone formation. The humanized monoclonal antibody romosozumab (brand name Evenity), indicated for osteoporosis to reduce the risk of fractures, was approved by the Food and Drug Administration for use in the USA in April 2019 and in the European Union in December 2019. Recent rodent data showed that romosozumab and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats [<xref rid="B19-ijms-23-08650" ref-type="bibr">19</xref>]. </p>
                <p>Romosozumab exhibits a dual mode of action. Firstly, it enhances bone formation; secondly, it inhibits bone resorption. This mechanism is shown in <xref rid="ijms-23-08650-f001" ref-type="fig">Figure 1</xref>. The development of romosozumab offers a safe and efficacious new drug to treat osteoporosis in postmenopausal women and men. In addition, the drug may be interesting to be tested in space travelers [<xref rid="B21-ijms-23-08650" ref-type="bibr">21</xref>].</p>
              </sec>
              <sec id="sec1dot2-ijms-23-08650">
                <title>1.2. Microgravity-Induced Bone Loss</title>
                <p>The decreased mechanical loading of weight-bearing bones caused by µ<italic toggle="yes">g</italic> in space leads to BL in humans after more than 4 months of space travel [<xref rid="B6-ijms-23-08650" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-08650" ref-type="bibr">7</xref>]. This is a result of increased BRS and unchanged or decreased BF, which is seen in different human studies both in space and during bed rest [<xref rid="B22-ijms-23-08650" ref-type="bibr">22</xref>,<xref rid="B23-ijms-23-08650" ref-type="bibr">23</xref>,<xref rid="B24-ijms-23-08650" ref-type="bibr">24</xref>] (see <xref rid="ijms-23-08650-f002" ref-type="fig">Figure 2</xref>). During the first 2 weeks of spaceflight, the BRS is especially exacerbated in humans [<xref rid="B25-ijms-23-08650" ref-type="bibr">25</xref>,<xref rid="B26-ijms-23-08650" ref-type="bibr">26</xref>,<xref rid="B27-ijms-23-08650" ref-type="bibr">27</xref>]. Microgravity releases calcium from bone in humans, which suppresses PTH and lowers circulating 1,25-dihydroxyvitamin D, although 25-dihydroxyvitamin D concentrations are still adequate. This leads to decreased calcium absorption in humans [<xref rid="B24-ijms-23-08650" ref-type="bibr">24</xref>,<xref rid="B26-ijms-23-08650" ref-type="bibr">26</xref>,<xref rid="B27-ijms-23-08650" ref-type="bibr">27</xref>,<xref rid="B28-ijms-23-08650" ref-type="bibr">28</xref>]. The decreased BF is found to be a consequence of impaired OB function and increased osteocyte apoptosis which was detected in both in vivo and vitro studies, as well as in a study focusing on rats [<xref rid="B5-ijms-23-08650" ref-type="bibr">5</xref>,<xref rid="B29-ijms-23-08650" ref-type="bibr">29</xref>,<xref rid="B30-ijms-23-08650" ref-type="bibr">30</xref>,<xref rid="B31-ijms-23-08650" ref-type="bibr">31</xref>]. The latter used a total of 50 4-week-old male Wistar rats, which were not suspended (<italic toggle="yes">n</italic> = 25) or suspended by the tail for 2, 4, and 7 days (<italic toggle="yes">n</italic> = 25 total). The right tibia metaphyses were used for histomorphometric analysis, the right femurs were used for TUNEL assays, and the metaphyseal area in left femurs was used for Western blot and immunoprecipitation analyses. The authors could show that, in the samples, components of the antiapoptotic pathway were downregulated during unloading. These findings contribute to µ<italic toggle="yes">g</italic>-induced BL of 0.5–1.5% every month in humans [<xref rid="B6-ijms-23-08650" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-08650" ref-type="bibr">7</xref>,<xref rid="B22-ijms-23-08650" ref-type="bibr">22</xref>].</p>
                <p>Because of the harmful effects induced on the human organ system by µ<italic toggle="yes">g</italic>, it is necessary for a successful space mission to develop countermeasures (CMs) against the µ<italic toggle="yes">g</italic>-induced changes [<xref rid="B33-ijms-23-08650" ref-type="bibr">33</xref>]. The CMs can be divided into (1) preflight CMs, which include physical exercise and physiological adaptation training, (2) inflight CMs, which include physical exercise, sensory–motor training, pharmaceuticals, and nutritional health, and (3) postflight CMs, which include rehabilitation [<xref rid="B34-ijms-23-08650" ref-type="bibr">34</xref>]. The Advanced resistive exercise device (ARED), a cycle ergometer, and treadmill exercise are current inflight CMs, routinely used directly against µ<italic toggle="yes">g</italic>-induced BL [<xref rid="B35-ijms-23-08650" ref-type="bibr">35</xref>]. The crewmembers on the International Space Station (ISS) are prescribed to do 2.5 h of exercise of personal preference per day for 6 days a week [<xref rid="B36-ijms-23-08650" ref-type="bibr">36</xref>].</p>
                <p>The ARED on board the ISS uses vacuum cylinders, making it effective in the µ<italic toggle="yes">g</italic> environment. It can provide up to 272 kg of concentric resistance, with a constant load through the range of motion of the body; during the eccentric phase, the ARED provides ~90% of the concentric load. Additionally, the ARED replicates the inertial characteristics normally experienced during gravity on Earth [<xref rid="B37-ijms-23-08650" ref-type="bibr">37</xref>].</p>
                <p>Crewmembers of the ISS can use the treadmill by a subject-loading device to fix themselves to the device. The subject loading makes the crewmembers able to exercise partially loaded, where the typical load is ~70%. The cycle ergometers have clipless pedals to fix the feet to the device and can provide up to 350 W load [<xref rid="B36-ijms-23-08650" ref-type="bibr">36</xref>].</p>
                <p>Furthermore, different drugs promoting bone formation have been studied. These so-called exercise pills include urolithin A and kartogenin. Urolithin A increased the exercise capacity and counteracted the decline of muscle function caused by age in rodents. Kartogenin was effective in promoting the differentiation of chondrocytes and the repair of cartilage in an in vitro study [<xref rid="B38-ijms-23-08650" ref-type="bibr">38</xref>,<xref rid="B39-ijms-23-08650" ref-type="bibr">39</xref>].</p>
              </sec>
            </sec>
            <sec id="sec2-ijms-23-08650">
              <title>2. Materials and Methods</title>
              <p>This systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [<xref rid="B40-ijms-23-08650" ref-type="bibr">40</xref>].</p>
              <sec id="sec2dot1-ijms-23-08650">
                <title>2.1. Eligibility Criteria</title>
                <p>The inclusion criteria were defined by the PICO parameters, which include population, intervention, comparison, and outcome [<xref rid="B41-ijms-23-08650" ref-type="bibr">41</xref>].</p>
                <p>The inclusion criteria were humans ≥18 years old, animal models, or cell cultures involved in BRS or BF. This population needed to be exposed to the intervention of either µ<italic toggle="yes">g</italic> or µ<italic toggle="yes">g</italic> analogs, or possible CMs against µ<italic toggle="yes">g</italic>-induced BL. The population exposed to the interventions needed to be compared to healthy individuals, controls, or baseline. The controls included human, animals, and cells involved in BRS or BF.</p>
                <p>The outcome needed to be either mechanism of µ<italic toggle="yes">g</italic>-induced BL or the effect of possible CMs against µ<italic toggle="yes">g</italic>-induced BL. The studies were not eligible if written in languages other than English or Danish, published before 1 January 2016, involving human individuals &lt; 18 years old, or a systematic review, meta-analysis, or case report.</p>
              </sec>
              <sec id="sec2dot2-ijms-23-08650">
                <title>2.2. Information Sources</title>
                <p>The literature search for this review was performed on the online repositories of PubMed (<uri>pubmed.ncbi.nlm.nih.gov</uri>) and Scopus (<uri>scopus.com</uri>), and the latest search was conducted on 28 March 2022.</p>
              </sec>
              <sec id="sec2dot3-ijms-23-08650">
                <title>2.3. Search</title>
                <p>Through a preliminary search in PubMed, relevant search terms were found as illustrated in <xref rid="ijms-23-08650-f003" ref-type="fig">Figure 3</xref>. Each search term in box 1 was combined with each search term in box 2 and all the filters in box 3 in several searches on 28 March 2022.</p>
              </sec>
              <sec id="sec2dot4-ijms-23-08650">
                <title>2.4. Study Selection</title>
                <p>The literature search resulted in a total of 1365 studies of which 883 were duplicates, leaving 482 studies. The reason for the duplicates is that each search term in box 1 of <xref rid="ijms-23-08650-f003" ref-type="fig">Figure 3</xref> was combined with each search term in box 2 in several searches. After title and abstract screening for eligibility criteria, there were 307 studies excluded, leaving 175 studies. It was not possible to retrieve eight studies; thus, 167 studies remained. The full articles were screened for the eligibility criteria and their relevance to the objectives of this systematic review, which yielded 37 studies (see individual reasons for exclusion in the flowchart in <xref rid="ijms-23-08650-f004" ref-type="fig">Figure 4</xref>).</p>
              </sec>
              <sec id="sec2dot5-ijms-23-08650">
                <title>2.5. Data Collection Process</title>
                <p>The author of this review developed a data extraction sheet, which was pilot-tested on three of the studies in case of any missing or redundant data. This was applied singlehandedly by the author of this review.</p>
              </sec>
              <sec id="sec2dot6-ijms-23-08650">
                <title>2.6. Data Items</title>
                <p>The data obtained from the studies were as follows: first author, year of publication, population characteristics (number of participants, age, and gender), intervention characteristics (µ<italic toggle="yes">g</italic>/µ<italic toggle="yes">g</italic> analog and possible CMs), and outcome of either mechanism of µg-related changes in bone density or the effect of possible CMs for µ<italic toggle="yes">g</italic>-related changes in bone density.</p>
              </sec>
              <sec id="sec2dot7-ijms-23-08650">
                <title>2.7. Risk of Bias in Individual Studies</title>
                <p>Studies in space are not only affected by µ<italic toggle="yes">g</italic>, but also affected by radiation, vibration during the launch from and return to Earth, and other environmental stressors in space, which also have the potential of inducing BL. This point cannot be excluded and may have impact on the findings. Low numbers of participants in space studies are also a problem since it makes it difficult to generalize the findings. Because of the risk of bias, these items were kept in mind when searching for studies.</p>
              </sec>
              <sec id="sec2dot8-ijms-23-08650">
                <title>2.8. Summary Measures</title>
                <p>The outcomes measured were changes in BMD and other bone characteristics, as well as markers of bone cell activity.</p>
              </sec>
              <sec id="sec2dot9-ijms-23-08650">
                <title>2.9. Risk of Bias across Studies</title>
                <p>Since the literature search only included published studies in English and Danish, there was a risk of both language bias and publication bias. These types of bias were kept in mind when searching for studies.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-ijms-23-08650">
              <title>3. Results</title>
              <sec id="sec3dot1-ijms-23-08650">
                <title>3.1. Study Selection</title>
                <p>The selection of the studies resulted in 37 studies as described in detail in <xref rid="sec2dot4-ijms-23-08650" ref-type="sec">Section 2.4</xref>. and in <xref rid="ijms-23-08650-f004" ref-type="fig">Figure 4</xref>.</p>
              </sec>
              <sec id="sec3dot2-ijms-23-08650">
                <title>3.2. Study Characteristics and Results of Individual Studies</title>
                <p>An overview of the results of the mechanisms of µg-related changes in bone density are provided in <xref rid="ijms-23-08650-t001" ref-type="table">Table 1</xref>, while the results of the possible CMs are given in <xref rid="ijms-23-08650-t002" ref-type="table">Table 2</xref>.</p>
                <p>BMD was decreased in humans by 0.9% after 6 months [<xref rid="B42-ijms-23-08650" ref-type="bibr">42</xref>] and 1% per month in space [<xref rid="B43-ijms-23-08650" ref-type="bibr">43</xref>]. The decrease in BMD in animals was 18–35.7% after 1 month [<xref rid="B45-ijms-23-08650" ref-type="bibr">45</xref>,<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>].</p>
                <p>Both markers of BRS [<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>,<xref rid="B47-ijms-23-08650" ref-type="bibr">47</xref>,<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>,<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>,<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>] and BF [<xref rid="B47-ijms-23-08650" ref-type="bibr">47</xref>,<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>] were elevated during µ<italic toggle="yes">g</italic> in humans and animals; meanwhile, several in vitro studies found inhibited OB differentiation markers (DMs) [<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>,<xref rid="B56-ijms-23-08650" ref-type="bibr">56</xref>,<xref rid="B57-ijms-23-08650" ref-type="bibr">57</xref>].</p>
                <p>Additionally, sclerostin was increased in humans [<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>], while mRNA expression of <italic toggle="yes">β-catenin</italic> was decreased in OBs [<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>].</p>
                <p>Resistive and locomotor exercise had an increasing effect on alkaline phosphatase (ALP) and attenuated the decrease in BMD during bed rest, respectively [<xref rid="B60-ijms-23-08650" ref-type="bibr">60</xref>,<xref rid="B61-ijms-23-08650" ref-type="bibr">61</xref>]. Resistive vibration exercise revealed an additional positive effect because it led to a greater proximal bone mineral content 6–24 months after bed rest compared to no exercise, which resistive exercise alone did not [<xref rid="B61-ijms-23-08650" ref-type="bibr">61</xref>]. The positive effect of exercise on BL is supported by several animal studies [<xref rid="B66-ijms-23-08650" ref-type="bibr">66</xref>,<xref rid="B67-ijms-23-08650" ref-type="bibr">67</xref>].</p>
                <p>BP, anti-RANKL, proteasome inhibitor (PI), pan-caspase inhibitor (PC-I), and interleukin-6 monoclonal antibody (IL-6 mAb) showed positive effects on BL [<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>,<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>,<xref rid="B71-ijms-23-08650" ref-type="bibr">71</xref>,<xref rid="B77-ijms-23-08650" ref-type="bibr">77</xref>], while SERMs and teriparatide did not reveal any effects on BL [<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>].</p>
                <p>Additionally, recombinant irisin (R-irisin), cell-free fat extract, and injection of cyclic mechanical stretch-treated bone mesenchymal stem cell-derived exosomes (CMS) had protective effects on the bones [<xref rid="B58-ijms-23-08650" ref-type="bibr">58</xref>,<xref rid="B59-ijms-23-08650" ref-type="bibr">59</xref>,<xref rid="B64-ijms-23-08650" ref-type="bibr">64</xref>,<xref rid="B69-ijms-23-08650" ref-type="bibr">69</xref>,<xref rid="B76-ijms-23-08650" ref-type="bibr">76</xref>]. </p>
                <p>Nanoparticles of hydroxyapatite (HA) loaded with risedronate were generated for bone-targeted drug delivery in ovariectomized rats (model for OP) [<xref rid="B78-ijms-23-08650" ref-type="bibr">78</xref>]. This nanoparticle-based formulation was superior to risedronate sodium monotherapy in this model of postmenopausal osteoporosis. In addition, the zoledronic acid (ZOL)/HA nanoparticle-based drug formulation was tested in ovariectomized rats [<xref rid="B79-ijms-23-08650" ref-type="bibr">79</xref>]. This formulation was highly effective in promoting BF. Moreover, the risedronate/zinc/HA-based nanomedicine revealed similar results. The findings showed that this nanomedicine had a therapeutic advantage over risedronate or risedronate/HA therapy for the treatment of osteoporosis in rats [<xref rid="B80-ijms-23-08650" ref-type="bibr">80</xref>]. Furthermore, strontium hydroxyapatite (SrHA) and zoledronic acid (ZOL) nanoparticle-based drug formulation exerted therapeutic advantages over ZOL or SrHA monotherapy in experimental OP in rats [<xref rid="B81-ijms-23-08650" ref-type="bibr">81</xref>].</p>
                <p>Antioxidants (AO) only showed a positive effect on BL in animal and cell studies [<xref rid="B72-ijms-23-08650" ref-type="bibr">72</xref>,<xref rid="B75-ijms-23-08650" ref-type="bibr">75</xref>], but not in human studies [<xref rid="B63-ijms-23-08650" ref-type="bibr">63</xref>].</p>
              </sec>
              <sec id="sec3dot3-ijms-23-08650">
                <title>3.3. Latest Clinical Trials</title>
                <p>An overview of a selection of the latest clinical trials of CMs against and mechanisms of µ<italic toggle="yes">g</italic>-induced BL listed in clinicaltrials.gov as assessed on 19 April 2022 is given in <xref rid="ijms-23-08650-t003" ref-type="table">Table 3</xref>. These studies primarily examined the effect of CMs on BMD and markers of bone cell activity in µ<italic toggle="yes">g</italic> analogs.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-ijms-23-08650">
              <title>4. Discussion</title>
              <sec id="sec4dot1-ijms-23-08650">
                <title>4.1. Summary of Evidence</title>
                <sec id="sec4dot1dot1-ijms-23-08650">
                  <title>4.1.1. Mechanisms of Microgravity-Related Changes in Bone Density</title>
                  <p>Earlier studies demonstrated a reduction in BMD of 0.5–1.5% per month in space [<xref rid="B6-ijms-23-08650" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-08650" ref-type="bibr">7</xref>]. This finding was supported by Burkhart et al., who reported a monthly reduction of 0.5–1% in BMD on the ISS in humans [<xref rid="B43-ijms-23-08650" ref-type="bibr">43</xref>]. However, Bilancio et al. reported only a 0.9–1.4% decrease in total BMD after 6 months on the ISS in humans [<xref rid="B42-ijms-23-08650" ref-type="bibr">42</xref>]. The rate of BMD reduction in mice seems to be higher because other studies found a reduction of 18–35.7% in BMD after 30 days in µ<italic toggle="yes">g</italic> [<xref rid="B45-ijms-23-08650" ref-type="bibr">45</xref>,<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>]. This difference could be caused by biological differences, because the skeleton of mice keeps growing after puberty and lacks Haversian systems among other elements compared to humans [<xref rid="B82-ijms-23-08650" ref-type="bibr">82</xref>]. The highest rate of age-related BL is found during the late perimenopause and beginning of the menopause, where the decrease of BL is up to 2.5% in the lumbar spine annually [<xref rid="B83-ijms-23-08650" ref-type="bibr">83</xref>,<xref rid="B84-ijms-23-08650" ref-type="bibr">84</xref>]. This indicates that the age-related rate of BL is substantially lower than the µ<italic toggle="yes">g</italic>-induced BMD reduction. However, the morphology of µ<italic toggle="yes">g</italic>-induced BL resembles the MP BL. BL caused by µ<italic toggle="yes">g</italic> reduced trabecular thickness and volume, and increased osteocyte apoptosis in the trabecular bone [<xref rid="B45-ijms-23-08650" ref-type="bibr">45</xref>,<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>,<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>]. This resembles the MP BL, because the MP BL increases trabecular remodeling [<xref rid="B14-ijms-23-08650" ref-type="bibr">14</xref>,<xref rid="B85-ijms-23-08650" ref-type="bibr">85</xref>]. Sibonga et al. reported that, after a 6 month-stay in space, four of 10 astronauts had an incomplete recovery from µ<italic toggle="yes">g</italic>-induced loss of BMD 2 years after returning to Earth [<xref rid="B44-ijms-23-08650" ref-type="bibr">44</xref>]. Interestingly, it was observed that only the trabecular BL, but not the cortical BL was recovered in mice 1 week after 4 weeks of spaceflight [<xref rid="B48-ijms-23-08650" ref-type="bibr">48</xref>].</p>
                  <p>The µ<italic toggle="yes">g</italic>-induced decrease in BMD is caused by an elevated bone resorption. Several studies found elevated markers of bone matrix degradation and OC markers and activation in both humans and animals [<xref rid="B47-ijms-23-08650" ref-type="bibr">47</xref>,<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>,<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>,<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>], which is supported by the 140% increase in BRS found by Gerbaix et al. [<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>]. However, markers of OBs were also elevated in several studies [<xref rid="B47-ijms-23-08650" ref-type="bibr">47</xref>,<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>]. These findings suggest that both OC and OB activities are increased during µ<italic toggle="yes">g</italic>, but that the process of BRS must be greater than the BF due to the decreased BMD. In untreated PMP osteoporotic women, there was an increase in BRS markers reported, whereas the BF markers differed more between different studies [<xref rid="B86-ijms-23-08650" ref-type="bibr">86</xref>,<xref rid="B87-ijms-23-08650" ref-type="bibr">87</xref>,<xref rid="B88-ijms-23-08650" ref-type="bibr">88</xref>,<xref rid="B89-ijms-23-08650" ref-type="bibr">89</xref>].</p>
                  <p>The increased sclerostin in humans and the decreased mRNA expression of <italic toggle="yes">β-catenin</italic> in OBs during µ<italic toggle="yes">g</italic> suggest that the heightened bone turnover (BT) is caused by inhibition of the Wnt/β-catenin signaling pathway, leading to increased BRS and decreased BF [<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>,<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>,<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>,<xref rid="B90-ijms-23-08650" ref-type="bibr">90</xref>]. However, numerous studies demonstrated that serum levels of sclerostin were significantly lower in PMP women with OP than in women without OP [<xref rid="B91-ijms-23-08650" ref-type="bibr">91</xref>,<xref rid="B92-ijms-23-08650" ref-type="bibr">92</xref>], which is different from the higher levels of sclerostin found during µ<italic toggle="yes">g</italic> [<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>,<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>]. The discrepancy in sclerostin levels could be a consequence of biological differences because the majority of the subjects in the µ<italic toggle="yes">g</italic> studies were male.</p>
                  <p>Several in vitro studies on cultured cells showed that the differentiation of OBs to osteocytes was inhibited, because OB DMs were decreased [<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>,<xref rid="B56-ijms-23-08650" ref-type="bibr">56</xref>,<xref rid="B57-ijms-23-08650" ref-type="bibr">57</xref>]. However, Cazzaniga et al. measured an increase in OB DMs after 4 days of µ<italic toggle="yes">g</italic> in human bone mesenchymal stem cells (bMSCs) [<xref rid="B55-ijms-23-08650" ref-type="bibr">55</xref>]. This inconsistency could be attributed to differences in the length of µ<italic toggle="yes">g</italic> exposure and different cell types. To compare these data with findings in PMP women, we must focus on estrogen deficiency in cells, with studies showing that several OB DMs were decreased in estrogen-depleted bMSCs and pre-OBs [<xref rid="B93-ijms-23-08650" ref-type="bibr">93</xref>,<xref rid="B94-ijms-23-08650" ref-type="bibr">94</xref>]. These data suggest that the estrogen-depleted MP OP induces a decrease in OB differentiation, which is similar to several studies on µ<italic toggle="yes">g</italic>-induced BL.</p>
                </sec>
                <sec id="sec4dot1dot2-ijms-23-08650">
                  <title>4.1.2. Possible Treatment Options for Microgravity-Induced Bone Loss</title>
                  <p>Both resistive exercise and locomotor exercise exhibited an increasing effect on the OB DM ALP and attenuated the decrease in BMD during bed rest, respectively [<xref rid="B60-ijms-23-08650" ref-type="bibr">60</xref>,<xref rid="B61-ijms-23-08650" ref-type="bibr">61</xref>]. Animal studies support the effectiveness of exercise on µ<italic toggle="yes">g</italic>-induced BL. Tibial compression during hindlimb unloading (HLU) had a protective effect on BL, while constrained dynamic loading increased bone volume fraction (BV/TV) [<xref rid="B67-ijms-23-08650" ref-type="bibr">67</xref>], trabecular number and thickness, and OB DM [<xref rid="B66-ijms-23-08650" ref-type="bibr">66</xref>].</p>
                  <p>Exercise is an important part of treatment of PMP OP [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>]. Several studies on PMP women showed an increase in BMD after resistive and aerobic exercise [<xref rid="B95-ijms-23-08650" ref-type="bibr">95</xref>,<xref rid="B96-ijms-23-08650" ref-type="bibr">96</xref>,<xref rid="B97-ijms-23-08650" ref-type="bibr">97</xref>,<xref rid="B98-ijms-23-08650" ref-type="bibr">98</xref>].</p>
                  <p>The pharmacological treatment of MP OP is an important part of the therapy according to the European and AACE guidelines [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>]. In addition, these treatments were tested in simulated µ<italic toggle="yes">g</italic> (s-µ<italic toggle="yes">g</italic>). BP and anti-RANKL inhibited the BRS and restored BMD in mice exposed to HLU close to mice in normal gravity in several studies [<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>,<xref rid="B71-ijms-23-08650" ref-type="bibr">71</xref>]. Furthermore, 3-month-old male Wistar rats subjected to right hindlimb immobilization for 10 weeks to induce osteopenia were treated with zoledronic acid and alfacalcidol. This combination therapy was more effective than each drug administered as a monotherapy for the treatment of disuse osteoporosis [<xref rid="B74-ijms-23-08650" ref-type="bibr">74</xref>]. However, SERM and teriparatide did not reveal any effect on BL [<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>], while BP, SERM, anti-RANKL, and teriparatide demonstrated a significant increase in BMD in MP women [<xref rid="B99-ijms-23-08650" ref-type="bibr">99</xref>,<xref rid="B100-ijms-23-08650" ref-type="bibr">100</xref>,<xref rid="B101-ijms-23-08650" ref-type="bibr">101</xref>,<xref rid="B102-ijms-23-08650" ref-type="bibr">102</xref>,<xref rid="B103-ijms-23-08650" ref-type="bibr">103</xref>,<xref rid="B104-ijms-23-08650" ref-type="bibr">104</xref>]. It should not be forgotten, however, that administration of BP and anti-RANKL can also cause some more or less severe side-effects. Overall, BP reduces fracture risk, but also induces changes in the bone material, which can reduce bone toughness [<xref rid="B105-ijms-23-08650" ref-type="bibr">105</xref>]. More severely, BP and anti-RANKL are also linked to the development of osteonecrosis of the jaw, a condition which can lead to life-threatening complications [<xref rid="B106-ijms-23-08650" ref-type="bibr">106</xref>,<xref rid="B107-ijms-23-08650" ref-type="bibr">107</xref>,<xref rid="B108-ijms-23-08650" ref-type="bibr">108</xref>]. The missing effect of raloxifene and teriparatide in µ<italic toggle="yes">g</italic> could be attributed to the biological difference between humans and mice. Additionally, the PI inhibited BRS, promoted BF, and induced an increase in BMD in mice exposed to HLU [<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>], while it decreased the area of resorbed bone in pre-OCs exposed to s-µ<italic toggle="yes">g</italic> [<xref rid="B77-ijms-23-08650" ref-type="bibr">77</xref>]. Ovariectomy in animals is used as a model for PMP OP [<xref rid="B109-ijms-23-08650" ref-type="bibr">109</xref>]. The PI increased the bone volume in ovariectomized animals, while it inhibited the OC formation and BRS in vitro, as well as stimulated OB differentiation [<xref rid="B110-ijms-23-08650" ref-type="bibr">110</xref>,<xref rid="B111-ijms-23-08650" ref-type="bibr">111</xref>]. PC-Is prevented the HLU-induced increase in osteocyte apoptosis, osteocyte RANKL expression, and endocortical resorption in mice [<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>]. PC-Is might have a positive effect on PMP OP. The OC differentiation was blocked by PC-Is in OCs [<xref rid="B112-ijms-23-08650" ref-type="bibr">112</xref>], and the decreases in BV/TV, as well as trabecular number and thickness, caused by ovariectomy in rats were alleviated [<xref rid="B113-ijms-23-08650" ref-type="bibr">113</xref>].</p>
                  <p>Furthermore, IL-6 mAb alleviates the µ<italic toggle="yes">g</italic>-induced BL by normalizing the BF and BRS, which leads to an increased BMD [<xref rid="B73-ijms-23-08650" ref-type="bibr">73</xref>]. Meanwhile, another study only measured a decrease in the number of OCs [<xref rid="B71-ijms-23-08650" ref-type="bibr">71</xref>]. This difference could be credited to different experimental protocols and strains of mice. Antibodies are already used in the treatment of MP OP, but not IL-6 mAb, which shows varying results. Some in vitro studies showed a suppressed development of OCs caused by IL-6 mAb [<xref rid="B114-ijms-23-08650" ref-type="bibr">114</xref>,<xref rid="B115-ijms-23-08650" ref-type="bibr">115</xref>]. Moreover, other studies, both in vitro and in vivo, showed no effect of IL-6 mAb on BRS, BL, or OC development [<xref rid="B114-ijms-23-08650" ref-type="bibr">114</xref>,<xref rid="B116-ijms-23-08650" ref-type="bibr">116</xref>,<xref rid="B117-ijms-23-08650" ref-type="bibr">117</xref>]. The use of IL-6 mAb in the treatment of MP OP is still quite unknown, and further studies are necessary.</p>
                  <p>Pharmacological treatments are vital for future space exploration, especially because the pharmacodynamics and pharmacokinetics might be different in space [<xref rid="B118-ijms-23-08650" ref-type="bibr">118</xref>,<xref rid="B119-ijms-23-08650" ref-type="bibr">119</xref>]. Absorption of paracetamol showed both slower and faster peak concentration during µ<italic toggle="yes">g</italic> in different studies [<xref rid="B118-ijms-23-08650" ref-type="bibr">118</xref>,<xref rid="B119-ijms-23-08650" ref-type="bibr">119</xref>,<xref rid="B120-ijms-23-08650" ref-type="bibr">120</xref>], while metabolism through P450 enzymes in rats was reduced by 0–50% after 7–14 days of spaceflight [<xref rid="B118-ijms-23-08650" ref-type="bibr">118</xref>,<xref rid="B121-ijms-23-08650" ref-type="bibr">121</xref>,<xref rid="B122-ijms-23-08650" ref-type="bibr">122</xref>,<xref rid="B123-ijms-23-08650" ref-type="bibr">123</xref>].</p>
                  <p>Furthermore, the effect of different supplements on µ<italic toggle="yes">g</italic>-induced BL was evaluated. R-irisin injection on mice during HLU prevented BL. There was no measurable loss of BMD, and R-irisin recovered the bone mass through attenuation of the OC inhibitor osteoprotegerin and increased activity and differentiation of OBs [<xref rid="B58-ijms-23-08650" ref-type="bibr">58</xref>,<xref rid="B64-ijms-23-08650" ref-type="bibr">64</xref>,<xref rid="B76-ijms-23-08650" ref-type="bibr">76</xref>]. In ovariectomized mice, R-irisin prevented trabecular BL and induced greater BMD, while the number of OBs was increased, and the number of OCs was decreased in parallel [<xref rid="B124-ijms-23-08650" ref-type="bibr">124</xref>]. Additionally, R-irisin returns the serum levels of osteocalcin, ALP, and tartrate-resistant acid phosphatase 5b in ovariectomized rats back to the same serum levels as non-ovariectomized rats [<xref rid="B125-ijms-23-08650" ref-type="bibr">125</xref>]. Addition of SCHN to bMSCs had a protective effect on µ<italic toggle="yes">g</italic>-induced reduction of ALP activity and a promoting effect on the deposition of hydroxyapatite crystals [<xref rid="B59-ijms-23-08650" ref-type="bibr">59</xref>]. Strontium ranelate is already used in OP treatment, where it showed a significant increase in BMD on PMP OP [<xref rid="B126-ijms-23-08650" ref-type="bibr">126</xref>,<xref rid="B127-ijms-23-08650" ref-type="bibr">127</xref>]. The injection of cell-free fat extract also has a positive effect on BL, because it alleviates the HLU-induced decrease in BV/TV, trabecular number, and cortical thickness [<xref rid="B69-ijms-23-08650" ref-type="bibr">69</xref>]. Furthermore, the injection of CMS in mice exposed to HLU increased BMD, BV/TV, cortical thickness, and trabecular thickness and number, while reducing the number of OCs [<xref rid="B70-ijms-23-08650" ref-type="bibr">70</xref>]. However, pulse-based diet and dietary protein and alkaline supplement did not show any effect on BL in humans [<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>,<xref rid="B62-ijms-23-08650" ref-type="bibr">62</xref>].</p>
                  <p>Application of AO had an effect in studies on cells and animals. Both nutraceuticals and polyphenols have an elevating effect on ALP activity in OBs exposed to s-µ<italic toggle="yes">g</italic> [<xref rid="B72-ijms-23-08650" ref-type="bibr">72</xref>,<xref rid="B75-ijms-23-08650" ref-type="bibr">75</xref>]. The reduced BL in rats could be due to alleviation of the µ<italic toggle="yes">g</italic>-induced inhibition of Wnt/β-catenin pathway, which enhances BF, because ALP, N-terminal propeptide of type 1 procollagen, and β-catenin are increased [<xref rid="B72-ijms-23-08650" ref-type="bibr">72</xref>]. However, no significant effect in humans on BL, who already consumed sufficient amounts of polyphenols, was found [<xref rid="B63-ijms-23-08650" ref-type="bibr">63</xref>], which questions the use of AO against µ<italic toggle="yes">g</italic>-induced BL. AO for MP women also showed variable results. A study found no effect of vitamin C in PMP women [<xref rid="B128-ijms-23-08650" ref-type="bibr">128</xref>]. However, other studies showed that the polyphenol resveratrol alone and curcumin combined with alendronate increased BMD in PMP women [<xref rid="B129-ijms-23-08650" ref-type="bibr">129</xref>,<xref rid="B130-ijms-23-08650" ref-type="bibr">130</xref>]. Here, the question remains whether the respective test subjects received adequate amounts of antioxidants before starting the study. These findings suggest that AO might have, under certain circumstances, an effect as a supplement to the treatment as advised in the European and AACE guidelines [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>]. </p>
                </sec>
              </sec>
              <sec id="sec4dot2-ijms-23-08650">
                <title>4.2. Strengths and Limitations</title>
                <p>There were several strengths of this review. The data were individually searched and collected from PubMed and Scopus, and then systemically and manually examined on the basis of PICO parameters. Another strength is that the results were based on the latest data from 2016 onward, and we did not use systematic reviews or meta-analyses, where data are interpreted by additional authors, or case reports in the results.</p>
                <p>There were also limitations to this work. This systematic review focused on the mechanisms behind µ<italic toggle="yes">g</italic>-induced BL and the possible treatment thereof on humans, but this review used studies examining animals and cell cultures, as well as studies examining s-µ<italic toggle="yes">g</italic>, which cannot replicate human studies in space. Nevertheless, the use of animals, cell cultures, and s-µ<italic toggle="yes">g</italic> have shown to be great alternatives to human studies in space [<xref rid="B131-ijms-23-08650" ref-type="bibr">131</xref>]; therefore, this review argues that studies of animals and cell cultures and studies using s-µ<italic toggle="yes">g</italic> are justified in this case. Furthermore, the studies on CM in real µ<italic toggle="yes">g</italic> were performed on cells and not any on animals or humans. Since pharmacological treatments can be different in space [<xref rid="B118-ijms-23-08650" ref-type="bibr">118</xref>,<xref rid="B119-ijms-23-08650" ref-type="bibr">119</xref>,<xref rid="B120-ijms-23-08650" ref-type="bibr">120</xref>,<xref rid="B121-ijms-23-08650" ref-type="bibr">121</xref>,<xref rid="B122-ijms-23-08650" ref-type="bibr">122</xref>,<xref rid="B123-ijms-23-08650" ref-type="bibr">123</xref>], this may also be a limitation.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec5-ijms-23-08650">
              <title>5. Conclusions</title>
              <p>Space travelers experience µ<italic toggle="yes">g</italic>, which enhances BL by 0.5–1.5% and reduces BMD per month in space. Many, but not all studies indicated an elevated BF and a greater increase in BRS, which led to increased BT and enhanced BL. One reason for this finding is, among others, the inhibition of the Wnt/β-catenin signaling pathway. Space travels will be more common in the future. Therefore, the enhanced BL needs to be alleviated so that it does not limit the possibility of space travel. To counteract the µ<italic toggle="yes">g</italic>-induced BL, numerous CMs have been proposed. Firstly, adequate nutrient intake, particularly sufficient amounts of energy, protein, calcium, and vitamin D and a diet high in alkaline precursors, might reduce bone loss. Secondly, different types of exercise showed a positive effect on BF and BMD. Thirdly, pharmacological treatment with BP, anti-RANKL, PI, PC-I, and IL-6 mAb decreased BRS and promoted BF, which in turn induced an increase in BMD. However, SERM and teriparatide did not reveal a significant effect on BL. Additionally, injection of r-irisin, cell-free fat extract, and CMS, as well as the addition of SCHN, showed positive effects on BL. However, AO and other supplements delivered various results. Although, several CMs revealed promising results, the results are still too variable and the number of replications for any human study are still too small to propose definitive guidelines for space travels and long-term space exploration.</p>
              <p>Taken together, more research is needed to expand the current knowledge of the mechanisms of µ<italic toggle="yes">g</italic>-induced BL. Studies on BL in space can be favorable and support the treatment of osteoporosis on Earth.</p>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p><bold>Publisher’s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, R.B.; methodology, R.B. and M.W.; validation, D.G., H.S., M.H., M.W. and M.I.; investigation, R.B.; resources, M.I.; writing—original draft preparation, R.B.; writing—review and editing, R.B., M.W., H.S., D.G. and M.H.; visualization, R.B.; supervision, D.G.; project administration, D.G. and M.I.; funding acquisition, D.G. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Institutional Review Board Statement</title>
              <p>Not applicable.</p>
            </notes>
            <notes>
              <title>Informed Consent Statement</title>
              <p>Not applicable.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability Statement</title>
              <p>Not applicable.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest.</p>
            </notes>
            <glossary>
              <title>Abbreviations</title>
              <array>
                <tbody>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">AACE</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">American Association of Clinical Endocrinologists</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ALF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Alfacalcidol</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ALP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Alkaline phosphatase</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">AO</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Antioxidants</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ARED</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Advanced resistive exercise device</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bisphosphonate</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BF</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone formation</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone loss</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BR/BRS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone resorption</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BMD</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone mineral density</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BT</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone turnover</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">bMSC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone mesenchymal stem cell</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">BV/TV</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Bone volume fraction</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Countermeasure</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">CMS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Cyclic mechanical stretch treated bone mesenchymal stem cell-derived exosomes</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">DM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Differentiation marker</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">HLU</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Hindlimb unloading</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">IL-6 mAb</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Interleukin-6 monoclonal antibody</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ISS</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">International Space Station</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">MP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Menopausal</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">OB</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Osteoblast</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">OC</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Osteoclast</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">OP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Osteoporosis</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PC-I</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Pan-caspase inhibitor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PI</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Proteasome inhibitor</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PMP</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Postmenopausal</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">PTH</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Parathyroid hormone</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RANKL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Receptor activator of nuclear factor κβ ligand</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">RHLI</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Right hindlimb immobilization</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">R-irisin</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Recombinant irisin</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SCHN</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Strontium-containing hydroxyapatite nanoparticles</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">SERM</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Selective estrogen receptor modulator</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">S-µ<italic toggle="yes">g</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Simulated microgravity</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">uCaV</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Urinary calcium excretion</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">uNTx</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Urinary N-telopeptide</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Wnt</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Wingless-related integration site</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">ZOL</td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Zoledronic acid</td>
                  </tr>
                  <tr>
                    <td align="left" valign="middle" rowspan="1" colspan="1">µ<italic toggle="yes">g</italic></td>
                    <td align="left" valign="middle" rowspan="1" colspan="1">Microgravity</td>
                  </tr>
                </tbody>
              </array>
            </glossary>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijms-23-08650">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morphew</surname>
                      <given-names>M.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Psychological and human factors in long duration spaceflight</article-title>
                  <source>McGill J. Med.</source>
                  <year>2001</year>
                  <volume>6</volume>
                  <fpage>74</fpage>
                  <lpage>80</lpage>
                  <pub-id pub-id-type="doi">10.26443/mjm.v6i1.555</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-ijms-23-08650">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Furukawa</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Nagamatsu</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Nenoi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fujimori</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kakinuma</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Katsube</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Tsuruoka</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Shirai</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Nakamura</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Space Radiation Biology for “Living in Space”</article-title>
                  <source>Biomed. Res. Int.</source>
                  <year>2020</year>
                  <volume>2020</volume>
                  <fpage>4703286</fpage>
                  <pub-id pub-id-type="doi">10.1155/2020/4703286</pub-id>
                  <pub-id pub-id-type="pmid">32337251</pub-id>
                </element-citation>
              </ref>
              <ref id="B3-ijms-23-08650">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shen</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Frishman</surname>
                      <given-names>W.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Spaceflight on Cardiovascular Physiology and Health</article-title>
                  <source>Cardiol Rev.</source>
                  <year>2019</year>
                  <volume>27</volume>
                  <fpage>122</fpage>
                  <lpage>126</lpage>
                  <pub-id pub-id-type="doi">10.1097/CRD.0000000000000236</pub-id>
                  <pub-id pub-id-type="pmid">30365406</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijms-23-08650">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hughes-Fulford</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>To infinity … and beyond! Human spaceflight and life science</article-title>
                  <source>FASEB J.</source>
                  <year>2011</year>
                  <volume>25</volume>
                  <fpage>2858</fpage>
                  <lpage>2864</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.11-0902ufm</pub-id>
                  <?supplied-pmid 21880668?>
                  <pub-id pub-id-type="pmid">21880668</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijms-23-08650">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Juhl</surname>
                      <given-names>O.J.T.</given-names>
                    </name>
                    <name>
                      <surname>Buettmann</surname>
                      <given-names>E.G.</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>DeNapoli</surname>
                      <given-names>R.C.</given-names>
                    </name>
                    <name>
                      <surname>Hoppock</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Donahue</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Update on the effects of microgravity on the musculoskeletal system</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2021</year>
                  <volume>7</volume>
                  <fpage>28</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41526-021-00158-4</pub-id>
                  <?supplied-pmid 34301942?>
                  <pub-id pub-id-type="pmid">34301942</pub-id>
                </element-citation>
              </ref>
              <ref id="B6-ijms-23-08650">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>LeBlanc</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Shackelford</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>West</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Oganov</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Bakulin</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Voronin</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone mineral and lean tissue loss after long duration space flight</article-title>
                  <source>J. Musculoskelet Neuronal Interact</source>
                  <year>2000</year>
                  <volume>1</volume>
                  <fpage>157</fpage>
                  <lpage>160</lpage>
                  <?supplied-pmid 15758512?>
                  <pub-id pub-id-type="pmid">15758512</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijms-23-08650">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vico</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>van Rietbergen</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Vilayphiou</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Linossier</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Locrelle</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Normand</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zouch</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gerbaix</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bonnet</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Novikov</surname>
                      <given-names>V.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cortical and Trabecular Bone Microstructure Did Not Recover at Weight-Bearing Skeletal Sites and Progressively Deteriorated at Non-Weight-Bearing Sites During the Year Following International Space Station Missions</article-title>
                  <source>J. Bone Mineral. Res.</source>
                  <year>2017</year>
                  <volume>32</volume>
                  <fpage>2010</fpage>
                  <lpage>2021</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.3188</pub-id>
                  <?supplied-pmid 28574653?>
                  <pub-id pub-id-type="pmid">28574653</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijms-23-08650">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Glaser</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Kaplan</surname>
                      <given-names>F.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteoporosis. Definition and clinical presentation</article-title>
                  <source>Spine</source>
                  <year>1997</year>
                  <volume>22</volume>
                  <fpage>12S</fpage>
                  <lpage>16S</lpage>
                  <pub-id pub-id-type="doi">10.1097/00007632-199712151-00003</pub-id>
                  <pub-id pub-id-type="pmid">9431639</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijms-23-08650">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Siris</surname>
                      <given-names>E.S.</given-names>
                    </name>
                    <name>
                      <surname>Adler</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Bilezikian</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bolognese</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Dawson-Hughes</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Favus</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Jan de Beur</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Khosla</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lane</surname>
                      <given-names>N.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>2014</year>
                  <volume>25</volume>
                  <fpage>1439</fpage>
                  <lpage>1443</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00198-014-2655-z</pub-id>
                  <pub-id pub-id-type="pmid">24577348</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijms-23-08650">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kanis</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Rizzoli</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Reginster</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>European guidance for the diagnosis and management of osteoporosis in postmenopausal women</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>2019</year>
                  <volume>30</volume>
                  <fpage>3</fpage>
                  <lpage>44</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00198-018-4704-5</pub-id>
                  <?supplied-pmid 30324412?>
                  <pub-id pub-id-type="pmid">30324412</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijms-23-08650">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Recker</surname>
                      <given-names>R.R.</given-names>
                    </name>
                    <name>
                      <surname>Davies</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Hinders</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Heaney</surname>
                      <given-names>R.P.</given-names>
                    </name>
                    <name>
                      <surname>Stegman</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Kimmel</surname>
                      <given-names>D.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone gain in young adult women</article-title>
                  <source>Jama</source>
                  <year>1992</year>
                  <volume>268</volume>
                  <fpage>2403</fpage>
                  <lpage>2408</lpage>
                  <pub-id pub-id-type="doi">10.1001/jama.1992.03490170075028</pub-id>
                  <?supplied-pmid 1404797?>
                  <pub-id pub-id-type="pmid">1404797</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijms-23-08650">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rizzoli</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Bianchi</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Garabédian</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>McKay</surname>
                      <given-names>H.A.</given-names>
                    </name>
                    <name>
                      <surname>Moreno</surname>
                      <given-names>L.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly</article-title>
                  <source>Bone</source>
                  <year>2010</year>
                  <volume>46</volume>
                  <fpage>294</fpage>
                  <lpage>305</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2009.10.005</pub-id>
                  <?supplied-pmid 19840876?>
                  <pub-id pub-id-type="pmid">19840876</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijms-23-08650">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hopper</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Green</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Nowson</surname>
                      <given-names>C.A.</given-names>
                    </name>
                    <name>
                      <surname>Young</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sherwin</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Kaymakci</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Larkins</surname>
                      <given-names>R.G.</given-names>
                    </name>
                    <name>
                      <surname>Wark</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic, common environment, and individual specific components of variance for bone mineral density in 10- to 26-year-old females: A twin study</article-title>
                  <source>Am. J. Epidemiol.</source>
                  <year>1998</year>
                  <volume>147</volume>
                  <fpage>17</fpage>
                  <lpage>29</lpage>
                  <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009361</pub-id>
                  <?supplied-pmid 9440394?>
                  <pub-id pub-id-type="pmid">9440394</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijms-23-08650">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Armas</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Recker</surname>
                      <given-names>R.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Pathophysiology of osteoporosis: New mechanistic insights</article-title>
                  <source>Endocrinol. Metab. Clin. N. Am.</source>
                  <year>2012</year>
                  <volume>41</volume>
                  <fpage>475</fpage>
                  <lpage>486</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ecl.2012.04.006</pub-id>
                  <?supplied-pmid 22877425?>
                  <pub-id pub-id-type="pmid">22877425</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijms-23-08650">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heaney</surname>
                      <given-names>R.P.</given-names>
                    </name>
                    <name>
                      <surname>Recker</surname>
                      <given-names>R.R.</given-names>
                    </name>
                    <name>
                      <surname>Saville</surname>
                      <given-names>P.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Menopausal changes in calcium balance performance</article-title>
                  <source>J. Lab. Clin. Med.</source>
                  <year>1978</year>
                  <volume>92</volume>
                  <fpage>953</fpage>
                  <lpage>963</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1753-4887.1983.tb07709.x</pub-id>
                  <pub-id pub-id-type="pmid">739173</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijms-23-08650">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Camacho</surname>
                      <given-names>P.M.</given-names>
                    </name>
                    <name>
                      <surname>Petak</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Binkley</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Diab</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Eldeiry</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Farooki</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>S.T.</given-names>
                    </name>
                    <name>
                      <surname>Hurley</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Kelly</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lewiecki</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis 2020 Update</article-title>
                  <source>Endocr. Pract.</source>
                  <year>2020</year>
                  <volume>26</volume>
                  <fpage>1</fpage>
                  <lpage>46</lpage>
                  <pub-id pub-id-type="doi">10.4158/GL-2020-0524SUPPL</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijms-23-08650">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zwart</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>B.L.</given-names>
                    </name>
                    <name>
                      <surname>Dlouhy</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Shackelford</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Koslovsky</surname>
                      <given-names>M.D.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Dietary acid load and bone turnover during long-duration spaceflight and bed rest</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>2018</year>
                  <volume>107</volume>
                  <fpage>834</fpage>
                  <lpage>844</lpage>
                  <pub-id pub-id-type="doi">10.1093/ajcn/nqy029</pub-id>
                  <pub-id pub-id-type="pmid">29722847</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijms-23-08650">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>An</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of Acid or Base Interventions on Bone Health: A Systematic Review, Meta-Analysis, and Meta-Regression</article-title>
                  <source>Adv. Nutr.</source>
                  <year>2021</year>
                  <volume>12</volume>
                  <fpage>1540</fpage>
                  <lpage>1557</lpage>
                  <pub-id pub-id-type="doi">10.1093/advances/nmab002</pub-id>
                  <pub-id pub-id-type="pmid">33684217</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijms-23-08650">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brent</surname>
                      <given-names>M.B.</given-names>
                    </name>
                    <name>
                      <surname>Brüel</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Thomsen</surname>
                      <given-names>J.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats</article-title>
                  <source>Bone</source>
                  <year>2022</year>
                  <volume>160</volume>
                  <fpage>116417</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2022.116417</pub-id>
                  <pub-id pub-id-type="pmid">35398589</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijms-23-08650">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Harris</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling</article-title>
                  <source>J. Biol. Chem.</source>
                  <year>2005</year>
                  <volume>280</volume>
                  <fpage>19883</fpage>
                  <lpage>19887</lpage>
                  <pub-id pub-id-type="doi">10.1074/jbc.M413274200</pub-id>
                  <pub-id pub-id-type="pmid">15778503</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijms-23-08650">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rauner</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Taipaleenmäki</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Tsourdi</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Winter</surname>
                      <given-names>E.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application</article-title>
                  <source>J. Clin. Med.</source>
                  <year>2021</year>
                  <volume>10</volume>
                  <elocation-id>787</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/jcm10040787</pub-id>
                  <?supplied-pmid 33669283?>
                  <pub-id pub-id-type="pmid">33669283</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijms-23-08650">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Man</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Graham</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Squires-Donelly</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Laslett</surname>
                      <given-names>A.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effects of microgravity on bone structure and function</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2022</year>
                  <volume>8</volume>
                  <fpage>9</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41526-022-00194-8</pub-id>
                  <pub-id pub-id-type="pmid">35383182</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijms-23-08650">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>McCoy</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Gazda</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zwart</surname>
                      <given-names>S.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Space flight calcium: Implications for astronaut health, spacecraft operations, and Earth</article-title>
                  <source>Nutrients</source>
                  <year>2012</year>
                  <volume>4</volume>
                  <fpage>2047</fpage>
                  <lpage>2068</lpage>
                  <pub-id pub-id-type="doi">10.3390/nu4122047</pub-id>
                  <?supplied-pmid 23250146?>
                  <pub-id pub-id-type="pmid">23250146</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijms-23-08650">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Wastney</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Morukov</surname>
                      <given-names>B.V.</given-names>
                    </name>
                    <name>
                      <surname>Larina</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Nyquist</surname>
                      <given-names>L.E.</given-names>
                    </name>
                    <name>
                      <surname>Abrams</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Taran</surname>
                      <given-names>E.N.</given-names>
                    </name>
                    <name>
                      <surname>Shih</surname>
                      <given-names>C.Y.</given-names>
                    </name>
                    <name>
                      <surname>Nillen</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Davis-Street</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Calcium metabolism before, during, and after a 3-mo spaceflight: Kinetic and biochemical changes</article-title>
                  <source>Am. J. Physiol.</source>
                  <year>1999</year>
                  <volume>277</volume>
                  <fpage>R1</fpage>
                  <lpage>R10</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpregu.1999.277.1.R1</pub-id>
                  <?supplied-pmid 10409251?>
                  <pub-id pub-id-type="pmid">10409251</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijms-23-08650">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caillot-Augusseau</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Vico</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Voroviev</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Souberbielle</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Zitterman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Alexandre</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Lafage-Proust</surname>
                      <given-names>M.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Space flight is associated with rapid decreases of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variation: Observations in two cosmonauts</article-title>
                  <source>Clin. Chem.</source>
                  <year>2000</year>
                  <volume>46</volume>
                  <fpage>1136</fpage>
                  <lpage>1143</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/46.8.1136</pub-id>
                  <?supplied-pmid 10926894?>
                  <pub-id pub-id-type="pmid">10926894</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijms-23-08650">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Caillot-Augusseau</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Lafage-Proust</surname>
                      <given-names>M.H.</given-names>
                    </name>
                    <name>
                      <surname>Soler</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Pernod</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Dubois</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Alexandre</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95)</article-title>
                  <source>Clin. Chem.</source>
                  <year>1998</year>
                  <volume>44</volume>
                  <fpage>578</fpage>
                  <lpage>585</lpage>
                  <pub-id pub-id-type="doi">10.1093/clinchem/44.3.578</pub-id>
                  <pub-id pub-id-type="pmid">9510865</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijms-23-08650">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Wastney</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>O’Brien</surname>
                      <given-names>K.O.</given-names>
                    </name>
                    <name>
                      <surname>Morukov</surname>
                      <given-names>B.V.</given-names>
                    </name>
                    <name>
                      <surname>Larina</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Abrams</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Davis-Street</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Oganov</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Shackelford</surname>
                      <given-names>L.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the mir space station</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2005</year>
                  <volume>20</volume>
                  <fpage>208</fpage>
                  <lpage>218</lpage>
                  <pub-id pub-id-type="doi">10.1359/JBMR.041105</pub-id>
                  <pub-id pub-id-type="pmid">15647814</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijms-23-08650">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Grimm</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Grosse</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wehland</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mann</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Reseland</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Sundaresan</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Corydon</surname>
                      <given-names>T.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The impact of microgravity on bone in humans</article-title>
                  <source>Bone</source>
                  <year>2016</year>
                  <volume>87</volume>
                  <fpage>44</fpage>
                  <lpage>56</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2015.12.057</pub-id>
                  <pub-id pub-id-type="pmid">27032715</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijms-23-08650">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bucaro</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Fertala</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Steinbeck</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ayyaswamy</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mukundakrishnan</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Shapiro</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Risbud</surname>
                      <given-names>M.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone cell survival in microgravity: Evidence that modeled microgravity increases osteoblast sensitivity to apoptogens</article-title>
                  <source>Ann. N. Y. Acad. Sci.</source>
                  <year>2004</year>
                  <volume>1027</volume>
                  <fpage>64</fpage>
                  <lpage>73</lpage>
                  <pub-id pub-id-type="doi">10.1196/annals.1324.007</pub-id>
                  <?supplied-pmid 15644346?>
                  <pub-id pub-id-type="pmid">15644346</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-ijms-23-08650">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bucaro</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Zahm</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Risbud</surname>
                      <given-names>M.V.</given-names>
                    </name>
                    <name>
                      <surname>Ayyaswamy</surname>
                      <given-names>P.S.</given-names>
                    </name>
                    <name>
                      <surname>Mukundakrishnan</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Steinbeck</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Shapiro</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Adams</surname>
                      <given-names>C.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>The effect of simulated microgravity on osteoblasts is independent of the induction of apoptosis</article-title>
                  <source>J. Cell. Biochem.</source>
                  <year>2007</year>
                  <volume>102</volume>
                  <fpage>483</fpage>
                  <lpage>495</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.21310</pub-id>
                  <?supplied-pmid 17520667?>
                  <pub-id pub-id-type="pmid">17520667</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijms-23-08650">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dufour</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Holy</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Marie</surname>
                      <given-names>P.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal unloading induces osteoblast apoptosis and targets α5β1-PI3K-Bcl-2 signaling in rat bone</article-title>
                  <source>Exp. Cell Res.</source>
                  <year>2007</year>
                  <volume>313</volume>
                  <fpage>394</fpage>
                  <lpage>403</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.yexcr.2006.10.021</pub-id>
                  <?supplied-pmid 17123509?>
                  <pub-id pub-id-type="pmid">17123509</pub-id>
                </element-citation>
              </ref>
              <ref id="B32-ijms-23-08650">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carmeliet</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Vico</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Bouillon</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Space flight: A challenge for normal bone homeostasis</article-title>
                  <source>Crit. Rev. Eukaryot. Gene Expr.</source>
                  <year>2001</year>
                  <volume>11</volume>
                  <fpage>131</fpage>
                  <lpage>144</lpage>
                  <pub-id pub-id-type="doi">10.1615/CritRevEukarGeneExpr.v11.i1-3.70</pub-id>
                  <?supplied-pmid 11693958?>
                  <pub-id pub-id-type="pmid">11693958</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijms-23-08650">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>DiFrancesco</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Olson</surname>
                      <given-names>J.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>The economics of microgravity research</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2015</year>
                  <volume>1</volume>
                  <fpage>15001</fpage>
                  <pub-id pub-id-type="doi">10.1038/npjmgrav.2015.1</pub-id>
                  <?supplied-pmid 28725707?>
                  <pub-id pub-id-type="pmid">28725707</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijms-23-08650">
                <label>34.</label>
                <element-citation publication-type="gov">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mars</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Bollweg</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Norsk</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>About Human Health Countermeasures (HHC)</article-title>
                  <comment>Available online: <ext-link xlink:href="http://www.nasa.gov/hrp/elements/hhc/about" ext-link-type="uri">http://www.nasa.gov/hrp/elements/hhc/about</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-04-05">(accessed on 5 April 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B35-ijms-23-08650">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Orwoll</surname>
                      <given-names>E.S.</given-names>
                    </name>
                    <name>
                      <surname>Adler</surname>
                      <given-names>R.A.</given-names>
                    </name>
                    <name>
                      <surname>Amin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Binkley</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lewiecki</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <name>
                      <surname>Petak</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Shapses</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Sinaki</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Watts</surname>
                      <given-names>N.B.</given-names>
                    </name>
                    <name>
                      <surname>Sibonga</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Skeletal health in long-duration astronauts: Nature, assessment, and management recommendations from the NASA Bone Summit</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2013</year>
                  <volume>28</volume>
                  <fpage>1243</fpage>
                  <lpage>1255</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.1948</pub-id>
                  <pub-id pub-id-type="pmid">23553962</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijms-23-08650">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Trappe</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Costill</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Gallagher</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Creer</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Peters</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Riley</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Fitts</surname>
                      <given-names>R.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise in space: Human skeletal muscle after 6 months aboard the International Space Station</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>2009</year>
                  <volume>106</volume>
                  <fpage>1159</fpage>
                  <lpage>1168</lpage>
                  <pub-id pub-id-type="doi">10.1152/japplphysiol.91578.2008</pub-id>
                  <?supplied-pmid 19150852?>
                  <pub-id pub-id-type="pmid">19150852</pub-id>
                </element-citation>
              </ref>
              <ref id="B37-ijms-23-08650">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Loehr</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>English</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Sibonga</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Spiering</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Hagan</surname>
                      <given-names>R.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Musculoskeletal adaptations to training with the advanced resistive exercise device</article-title>
                  <source>Med. Sci. Sports Exerc.</source>
                  <year>2011</year>
                  <volume>43</volume>
                  <fpage>146</fpage>
                  <lpage>156</lpage>
                  <pub-id pub-id-type="doi">10.1249/MSS.0b013e3181e4f161</pub-id>
                  <pub-id pub-id-type="pmid">20473227</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijms-23-08650">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Furukawa</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chatani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Higashitani</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Higashibata</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kawano</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Nikawa</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Numaga-Tomita</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ogura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Sato</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Sehara-Fujisawa</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Findings from recent studies by the Japan Aerospace Exploration Agency examining musculoskeletal atrophy in space and on Earth</article-title>
                  <source>NPJ Microgravity</source>
                  <year>2021</year>
                  <volume>7</volume>
                  <fpage>18</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41526-021-00145-9</pub-id>
                  <?supplied-pmid 34039989?>
                  <pub-id pub-id-type="pmid">34039989</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijms-23-08650">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Johnson</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tremblay</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Payette</surname>
                      <given-names>J.N.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Bouchez</surname>
                      <given-names>L.C.</given-names>
                    </name>
                    <name>
                      <surname>Meeusen</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Althage</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Cho</surname>
                      <given-names>C.Y.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>A stem cell-based approach to cartilage repair</article-title>
                  <source>Science</source>
                  <year>2012</year>
                  <volume>336</volume>
                  <fpage>717</fpage>
                  <lpage>721</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.1215157</pub-id>
                  <pub-id pub-id-type="pmid">22491093</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijms-23-08650">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liberati</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Altman</surname>
                      <given-names>D.G.</given-names>
                    </name>
                    <name>
                      <surname>Tetzlaff</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Mulrow</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Gøtzsche</surname>
                      <given-names>P.C.</given-names>
                    </name>
                    <name>
                      <surname>Ioannidis</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Clarke</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Devereaux</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Kleijnen</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Moher</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration</article-title>
                  <source>Ann. Intern. Med.</source>
                  <year>2009</year>
                  <volume>151</volume>
                  <fpage>W65</fpage>
                  <lpage>W94</lpage>
                  <pub-id pub-id-type="doi">10.7326/0003-4819-151-4-200908180-00136</pub-id>
                  <pub-id pub-id-type="pmid">19622512</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-ijms-23-08650">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Aslam</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Emmanuel</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Formulating a researchable question: A critical step for facilitating good clinical research</article-title>
                  <source>Indian J. Sex. Transm. Dis. AIDS</source>
                  <year>2010</year>
                  <volume>31</volume>
                  <fpage>47</fpage>
                  <lpage>50</lpage>
                  <pub-id pub-id-type="doi">10.4103/0253-7184.69003</pub-id>
                  <pub-id pub-id-type="pmid">21808439</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijms-23-08650">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bilancio</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Cavallo</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Lombardi</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Guarino</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Cozza</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Giordano</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Cirillo</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Urea and minerals monitoring in space missions by spot samples of saliva and urine</article-title>
                  <source>Aerosp. Med. Hum. Perform.</source>
                  <year>2019</year>
                  <volume>90</volume>
                  <fpage>43</fpage>
                  <lpage>47</lpage>
                  <pub-id pub-id-type="doi">10.3357/AMHP.5200.2019</pub-id>
                  <?supplied-pmid 30579377?>
                  <pub-id pub-id-type="pmid">30579377</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijms-23-08650">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Burkhart</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Allaire</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>D.E.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Keaveny</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Bouxsein</surname>
                      <given-names>M.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of Long-Duration Spaceflight on Vertebral Strength and Risk of Spine Fracture</article-title>
                  <source>J. Bone Mineral. Res.</source>
                  <year>2020</year>
                  <volume>35</volume>
                  <fpage>269</fpage>
                  <lpage>276</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.3881</pub-id>
                  <?supplied-pmid 31670861?>
                  <pub-id pub-id-type="pmid">31670861</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-ijms-23-08650">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sibonga</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <name>
                      <surname>Spector</surname>
                      <given-names>E.R.</given-names>
                    </name>
                    <name>
                      <surname>Keyak</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Zwart</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Lang</surname>
                      <given-names>T.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Use of Quantitative Computed Tomography to Assess for Clinically-relevant Skeletal Effects of Prolonged Spaceflight on Astronaut Hips</article-title>
                  <source>J. Clin. Densitom.</source>
                  <year>2020</year>
                  <volume>23</volume>
                  <fpage>155</fpage>
                  <lpage>164</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jocd.2019.08.005</pub-id>
                  <?supplied-pmid 31558405?>
                  <pub-id pub-id-type="pmid">31558405</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijms-23-08650">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Berg-Johansen</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Liebenberg</surname>
                      <given-names>E.C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Macias</surname>
                      <given-names>B.R.</given-names>
                    </name>
                    <name>
                      <surname>Hargens</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Lotz</surname>
                      <given-names>J.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Spaceflight-induced bone loss alters failure mode and reduces bending strength in murine spinal segments</article-title>
                  <source>J. Orthop. Res.</source>
                  <year>2016</year>
                  <volume>34</volume>
                  <fpage>48</fpage>
                  <lpage>57</lpage>
                  <pub-id pub-id-type="doi">10.1002/jor.23029</pub-id>
                  <?supplied-pmid 26285046?>
                  <pub-id pub-id-type="pmid">26285046</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijms-23-08650">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gerbaix</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Gnyubkin</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Farlay</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Olivier</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Ammann</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Courbon</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Laroche</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Genthial</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Follet</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Peyrin</surname>
                      <given-names>F.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>One-month spaceflight compromises the bone microstructure, tissue-level mechanical properties, osteocyte survival and lacunae volume in mature mice skeletons</article-title>
                  <source>Sci. Rep.</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>2659</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-03014-2</pub-id>
                  <?supplied-pmid 28572612?>
                  <pub-id pub-id-type="pmid">28572612</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijms-23-08650">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chatani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Morimoto</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Takeyama</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Mantoku</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Tanigawa</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Kubota</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Uchida</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Tanigaki</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Shirakawa</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Acute transcriptional up-regulation specific to osteoblasts/osteoclasts in medaka fish immediately after exposure to microgravity</article-title>
                  <source>Sci. Rep.</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>39545</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep39545</pub-id>
                  <pub-id pub-id-type="pmid">28004797</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijms-23-08650">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>von Kroge</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Wölfel</surname>
                      <given-names>E.M.</given-names>
                    </name>
                    <name>
                      <surname>Buravkova</surname>
                      <given-names>L.B.</given-names>
                    </name>
                    <name>
                      <surname>Atiakshin</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Markina</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Schinke</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Rolvien</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Busse</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Jähn-Rickert</surname>
                      <given-names>K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone loss recovery in mice following microgravity with concurrent bone-compartment-specific osteocyte characteristics</article-title>
                  <source>Eur. Cell Mater.</source>
                  <year>2021</year>
                  <volume>42</volume>
                  <fpage>220</fpage>
                  <lpage>231</lpage>
                  <pub-id pub-id-type="doi">10.22203/eCM.v042a16</pub-id>
                  <pub-id pub-id-type="pmid">34642917</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijms-23-08650">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bonnefoy</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Baselet</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Moser</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Ghislin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Miranda</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Riant</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Vermeesen</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Keiler</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Baatout</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Choukér</surname>
                      <given-names>A.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>B-Cell Homeostasis Is Maintained During Two Months of Head-Down Tilt Bed Rest With or Without Antioxidant Supplementation</article-title>
                  <source>Front. Immunol.</source>
                  <year>2022</year>
                  <volume>13</volume>
                  <fpage>830662</fpage>
                  <pub-id pub-id-type="doi">10.3389/fimmu.2022.830662</pub-id>
                  <?supplied-pmid 35251019?>
                  <pub-id pub-id-type="pmid">35251019</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijms-23-08650">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bemben</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Baker</surname>
                      <given-names>B.S.</given-names>
                    </name>
                    <name>
                      <surname>Buchanan</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Ade</surname>
                      <given-names>C.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Circulating MiR-21 expression is upregulated after 30° days of head-down tilt bed rest</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>2021</year>
                  <volume>32</volume>
                  <fpage>1369</fpage>
                  <lpage>1378</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00198-020-05805-2</pub-id>
                  <pub-id pub-id-type="pmid">33432460</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-ijms-23-08650">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Buehlmeier</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Frings-Meuthen</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mohorko</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lau</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Mazzucco</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Ferretti</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Biolo</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pisot</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Simunic</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Rittweger</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Markers of bone metabolism during 14 days of bed rest in young and older men</article-title>
                  <source>J. Musculoskelet Neuronal Interact.</source>
                  <year>2017</year>
                  <volume>17</volume>
                  <fpage>399</fpage>
                  <lpage>408</lpage>
                  <pub-id pub-id-type="pmid">28250244</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-ijms-23-08650">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cabahug-Zuckerman</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Frikha-Benayed</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Majeska</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Tuthill</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Yakar</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Judex</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Schaffler</surname>
                      <given-names>M.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteocyte Apoptosis Caused by Hindlimb Unloading is Required to Trigger Osteocyte RANKL Production and Subsequent Resorption of Cortical and Trabecular Bone in Mice Femurs</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2016</year>
                  <volume>31</volume>
                  <fpage>1356</fpage>
                  <lpage>1365</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.2807</pub-id>
                  <?supplied-pmid 26852281?>
                  <pub-id pub-id-type="pmid">26852281</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-ijms-23-08650">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chowdhury</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Akel</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Jamshidi-Parsian</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Gaddy</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Griffin</surname>
                      <given-names>R.J.</given-names>
                    </name>
                    <name>
                      <surname>Yadlapalli</surname>
                      <given-names>J.S.K.</given-names>
                    </name>
                    <name>
                      <surname>Dobretsov</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Degenerative tissue responses to space-like radiation doses in a rodent model of simulated microgravity</article-title>
                  <source>Ann. Clin. Lab. Sci.</source>
                  <year>2016</year>
                  <volume>46</volume>
                  <fpage>190</fpage>
                  <lpage>197</lpage>
                  <?supplied-pmid 27098627?>
                  <pub-id pub-id-type="pmid">27098627</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-ijms-23-08650">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Yin</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Huai</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>miR-138–5p negatively regulates osteoblast differentiation through inhibiting β-catenin under simulated microgravity in MC3T3-E1 cells</article-title>
                  <source>Acta Astronaut.</source>
                  <year>2021</year>
                  <volume>182</volume>
                  <fpage>240</fpage>
                  <lpage>250</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.actaastro.2021.01.052</pub-id>
                </element-citation>
              </ref>
              <ref id="B55-ijms-23-08650">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cazzaniga</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Maier</surname>
                      <given-names>J.A.M.</given-names>
                    </name>
                    <name>
                      <surname>Castiglioni</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of simulated microgravity on human bone stem cells: New hints for space medicine</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2016</year>
                  <volume>473</volume>
                  <fpage>181</fpage>
                  <lpage>186</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.03.075</pub-id>
                  <?supplied-pmid 27005819?>
                  <pub-id pub-id-type="pmid">27005819</pub-id>
                </element-citation>
              </ref>
              <ref id="B56-ijms-23-08650">
                <label>56.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kuang</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity inhibits osteogenic differentiation of mesenchymal stem cells via depolymerizing F-actin to impede TAZ nuclear translocation</article-title>
                  <source>Sci. Rep.</source>
                  <year>2016</year>
                  <volume>6</volume>
                  <fpage>30322</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep30322</pub-id>
                  <?supplied-pmid 27444891?>
                  <pub-id pub-id-type="pmid">27444891</pub-id>
                </element-citation>
              </ref>
              <ref id="B57-ijms-23-08650">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Dong</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Cao</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Hu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>MiR-30 family members inhibit osteoblast differentiation by suppressing Runx2 under unloading conditions in MC3T3-E1 cells</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2020</year>
                  <volume>522</volume>
                  <fpage>164</fpage>
                  <lpage>170</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.11.057</pub-id>
                  <?supplied-pmid 31757419?>
                  <pub-id pub-id-type="pmid">31757419</pub-id>
                </element-citation>
              </ref>
              <ref id="B58-ijms-23-08650">
                <label>58.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Colucci</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Colaianni</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Brunetti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Ferranti</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Mascetti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Grano</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission</article-title>
                  <source>FASEB J.</source>
                  <year>2020</year>
                  <volume>34</volume>
                  <fpage>10096</fpage>
                  <lpage>10106</lpage>
                  <pub-id pub-id-type="doi">10.1096/fj.202000216R</pub-id>
                  <?supplied-pmid 32539174?>
                  <pub-id pub-id-type="pmid">32539174</pub-id>
                </element-citation>
              </ref>
              <ref id="B59-ijms-23-08650">
                <label>59.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cristofaro</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Pani</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pascucci</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Mariani</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Balsamo</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Donati</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Mascetti</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Rea</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Rizzo</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Visai</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The NATO project: Nanoparticle-based countermeasures for microgravity-induced osteoporosis</article-title>
                  <source>Sci. Rep.</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <fpage>17141</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-019-53481-y</pub-id>
                  <?supplied-pmid 31748575?>
                  <pub-id pub-id-type="pmid">31748575</pub-id>
                </element-citation>
              </ref>
              <ref id="B60-ijms-23-08650">
                <label>60.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cavanagh</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Novotny</surname>
                      <given-names>S.C.</given-names>
                    </name>
                    <name>
                      <surname>Genc</surname>
                      <given-names>K.O.</given-names>
                    </name>
                    <name>
                      <surname>Englehaupt</surname>
                      <given-names>R.K.</given-names>
                    </name>
                    <name>
                      <surname>Owings</surname>
                      <given-names>T.M.</given-names>
                    </name>
                    <name>
                      <surname>Comstock</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Cardoso</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Ilaslan</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Replacement of daily load attenuates but does not prevent changes to the musculoskeletal system during bed rest</article-title>
                  <source>Bone Rep.</source>
                  <year>2016</year>
                  <volume>5</volume>
                  <fpage>299</fpage>
                  <lpage>307</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bonr.2016.10.001</pub-id>
                  <pub-id pub-id-type="pmid">28580400</pub-id>
                </element-citation>
              </ref>
              <ref id="B61-ijms-23-08650">
                <label>61.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Belavý</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Baecker</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Armbrecht</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Beller</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Buehlmeier</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Frings-Meuthen</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Rittweger</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Roth</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Felsenberg</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serum sclerostin and DKK1 in relation to exercise against bone loss in experimental bed rest</article-title>
                  <source>J. Bone Mineral. Metab.</source>
                  <year>2016</year>
                  <volume>34</volume>
                  <fpage>354</fpage>
                  <lpage>365</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00774-015-0681-3</pub-id>
                </element-citation>
              </ref>
              <ref id="B62-ijms-23-08650">
                <label>62.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gao</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Duff</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Chizen</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Zello</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Chilibeck</surname>
                      <given-names>P.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Effect of a Low Glycemic Index Pulse-Based Diet on Insulin Sensitivity, Insulin Resistance, Bone Resorption and Cardiovascular Risk Factors during Bed Rest</article-title>
                  <source>Nutrients</source>
                  <year>2019</year>
                  <volume>11</volume>
                  <elocation-id>2012</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/nu11092012</pub-id>
                  <?supplied-pmid 31461862?>
                  <pub-id pub-id-type="pmid">31461862</pub-id>
                </element-citation>
              </ref>
              <ref id="B63-ijms-23-08650">
                <label>63.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Austermann</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Baecker</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Zwart</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Fimmers</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Frippiat</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Stehle</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Smith</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Heer</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Antioxidant Supplementation Does Not Affect Bone Turnover Markers During 60 Days of 6° Head-Down Tilt Bed Rest: Results from an Exploratory Randomized Controlled Trial</article-title>
                  <source>J. Nutr.</source>
                  <year>2021</year>
                  <volume>151</volume>
                  <fpage>1527</fpage>
                  <lpage>1538</lpage>
                  <pub-id pub-id-type="doi">10.1093/jn/nxab036</pub-id>
                  <pub-id pub-id-type="pmid">33831949</pub-id>
                </element-citation>
              </ref>
              <ref id="B64-ijms-23-08650">
                <label>64.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Colaianni</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mongelli</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Cuscito</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Pignataro</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Lippo</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Spiro</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Notarnicola</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Severi</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Passeri</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Mori</surname>
                      <given-names>G.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice</article-title>
                  <source>Sci. Rep.</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>2811</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-017-02557-8</pub-id>
                  <?supplied-pmid 28588307?>
                  <pub-id pub-id-type="pmid">28588307</pub-id>
                </element-citation>
              </ref>
              <ref id="B65-ijms-23-08650">
                <label>65.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ding</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Tian</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Peng</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Tang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>C.P.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anti-RANKL monoclonal antibody and bortezomib prevent mechanical unloading-induced bone loss</article-title>
                  <source>J. Bone Mineral. Metab.</source>
                  <year>2021</year>
                  <volume>39</volume>
                  <fpage>974</fpage>
                  <lpage>983</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00774-021-01246-x</pub-id>
                  <?supplied-pmid 34212247?>
                  <pub-id pub-id-type="pmid">34212247</pub-id>
                </element-citation>
              </ref>
              <ref id="B66-ijms-23-08650">
                <label>66.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Han</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X.C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>R.X.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of constrained dynamic loading, CKIP-1 gene knockout and combination stimulations on bone loss caused by mechanical unloading</article-title>
                  <source>Mol. Med. Rep.</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <fpage>2506</fpage>
                  <lpage>2514</lpage>
                  <pub-id pub-id-type="doi">10.3892/mmr.2018.9222</pub-id>
                  <?supplied-pmid 29956799?>
                  <pub-id pub-id-type="pmid">29956799</pub-id>
                </element-citation>
              </ref>
              <ref id="B67-ijms-23-08650">
                <label>67.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>DeLong</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Friedman</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Tucker</surname>
                      <given-names>S.M.</given-names>
                    </name>
                    <name>
                      <surname>Krause</surname>
                      <given-names>A.R.</given-names>
                    </name>
                    <name>
                      <surname>Kunselman</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Donahue</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Lewis</surname>
                      <given-names>G.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Protective Effects of Controlled Mechanical Loading of Bone in C57BL6/J Mice Subject to Disuse</article-title>
                  <source>JBMR Plus</source>
                  <year>2020</year>
                  <volume>4</volume>
                  <fpage>e10322</fpage>
                  <pub-id pub-id-type="doi">10.1002/jbm4.10322</pub-id>
                  <?supplied-pmid 32161839?>
                  <pub-id pub-id-type="pmid">32161839</pub-id>
                </element-citation>
              </ref>
              <ref id="B68-ijms-23-08650">
                <label>68.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Lv</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Fang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Shang</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Static magnetic field of 0.2–0.4 T promotes the recovery of hindlimb unloading-induced bone loss in mice</article-title>
                  <source>Int. J. Radiat. Biol.</source>
                  <year>2021</year>
                  <volume>97</volume>
                  <fpage>746</fpage>
                  <lpage>754</lpage>
                  <pub-id pub-id-type="doi">10.1080/09553002.2021.1900944</pub-id>
                  <pub-id pub-id-type="pmid">33720796</pub-id>
                </element-citation>
              </ref>
              <ref id="B69-ijms-23-08650">
                <label>69.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Du</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Deng</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Cell-Free Fat Extract Prevents Tail Suspension–Induced Bone Loss by Inhibiting Osteocyte Apoptosis</article-title>
                  <source>Front. Bioeng. Biotechnol.</source>
                  <year>2022</year>
                  <volume>10</volume>
                  <fpage>818572</fpage>
                  <pub-id pub-id-type="doi">10.3389/fbioe.2022.818572</pub-id>
                  <?supplied-pmid 35174144?>
                  <pub-id pub-id-type="pmid">35174144</pub-id>
                </element-citation>
              </ref>
              <ref id="B70-ijms-23-08650">
                <label>70.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiao</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Zuo</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Tao</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Peng</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exosomes derived from cyclic mechanical stretch-exposed bone marrow mesenchymal stem cells inhibit RANKL-induced osteoclastogenesis through the NF-κB signaling pathway</article-title>
                  <source>Ann. Transl. Med.</source>
                  <year>2021</year>
                  <volume>9</volume>
                  <fpage>798</fpage>
                  <pub-id pub-id-type="doi">10.21037/atm-21-1838</pub-id>
                  <pub-id pub-id-type="pmid">34268411</pub-id>
                </element-citation>
              </ref>
              <ref id="B71-ijms-23-08650">
                <label>71.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wakabayashi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Miyamura</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Nagao</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Kato</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Naito</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Sudo</surname>
                      <given-names>A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Functional Block of Interleukin-6 Reduces a Bone Pain Marker but Not Bone Loss in Hindlimb-Unloaded Mice</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2020</year>
                  <volume>21</volume>
                  <elocation-id>3521</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms21103521</pub-id>
                  <?supplied-pmid 32429268?>
                  <pub-id pub-id-type="pmid">32429268</pub-id>
                </element-citation>
              </ref>
              <ref id="B72-ijms-23-08650">
                <label>72.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diao</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Polyphenols (S3) Isolated from Cone Scales of Pinus koraiensis Alleviate Decreased Bone Formation in Rat under Simulated Microgravity</article-title>
                  <source>Sci. Rep.</source>
                  <year>2018</year>
                  <volume>8</volume>
                  <fpage>12719</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41598-018-30992-8</pub-id>
                  <pub-id pub-id-type="pmid">30143710</pub-id>
                </element-citation>
              </ref>
              <ref id="B73-ijms-23-08650">
                <label>73.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>He</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Yin</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Hao</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Blockade of IL-6 alleviates bone loss induced by modeled microgravity in mice</article-title>
                  <source>Can. J. Physiol. Pharmacol.</source>
                  <year>2020</year>
                  <volume>98</volume>
                  <fpage>678</fpage>
                  <lpage>683</lpage>
                  <pub-id pub-id-type="doi">10.1139/cjpp-2019-0632</pub-id>
                  <pub-id pub-id-type="pmid">32787688</pub-id>
                </element-citation>
              </ref>
              <ref id="B74-ijms-23-08650">
                <label>74.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khajuria</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Disha</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mahapatra</surname>
                      <given-names>D.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Additive effect of zoledronic acid and alfacalcidol in the treatment of disuse osteoporosis in rats</article-title>
                  <source>Rev. Bras. Reumatol.</source>
                  <year>2015</year>
                  <volume>55</volume>
                  <fpage>240</fpage>
                  <lpage>250</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.rbr.2014.08.007</pub-id>
                  <pub-id pub-id-type="pmid">25440697</pub-id>
                </element-citation>
              </ref>
              <ref id="B75-ijms-23-08650">
                <label>75.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Braveboy-Wagner</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sharoni</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Lelkes</surname>
                      <given-names>P.I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Nutraceuticals synergistically promote osteogenesis in cultured 7F2 osteoblasts and mitigate inhibition of differentiation and maturation in simulated microgravity</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2022</year>
                  <volume>23</volume>
                  <elocation-id>136</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms23010136</pub-id>
                  <?supplied-pmid 35008559?>
                  <pub-id pub-id-type="pmid">35008559</pub-id>
                </element-citation>
              </ref>
              <ref id="B76-ijms-23-08650">
                <label>76.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Yin</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>X.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Recombinant irisin prevents the reduction of osteoblast differentiation induced by stimulated microgravity through increasing β-catenin expression</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2020</year>
                  <volume>21</volume>
                  <elocation-id>1259</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms21041259</pub-id>
                  <?supplied-pmid 32070052?>
                  <pub-id pub-id-type="pmid">32070052</pub-id>
                </element-citation>
              </ref>
              <ref id="B77-ijms-23-08650">
                <label>77.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ethiraj</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Ottinger</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Singh</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Haire</surname>
                      <given-names>K.M.</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>S.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Proteasome inhibition suppress microgravity elevated RANK signaling during osteoclast differentiation</article-title>
                  <source>Cytokine</source>
                  <year>2020</year>
                  <volume>125</volume>
                  <fpage>154821</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.cyto.2019.154821</pub-id>
                  <?supplied-pmid 31470364?>
                  <pub-id pub-id-type="pmid">31470364</pub-id>
                </element-citation>
              </ref>
              <ref id="B78-ijms-23-08650">
                <label>78.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sahana</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Khajuria</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mahapatra</surname>
                      <given-names>D.R.</given-names>
                    </name>
                    <name>
                      <surname>Bhat</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Suresh</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Rao</surname>
                      <given-names>R.R.</given-names>
                    </name>
                    <name>
                      <surname>Mariappan</surname>
                      <given-names>L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis</article-title>
                  <source>J. Biomed. Nanotechnol.</source>
                  <year>2013</year>
                  <volume>9</volume>
                  <fpage>193</fpage>
                  <lpage>201</lpage>
                  <pub-id pub-id-type="doi">10.1166/jbn.2013.1482</pub-id>
                  <pub-id pub-id-type="pmid">23627045</pub-id>
                </element-citation>
              </ref>
              <ref id="B79-ijms-23-08650">
                <label>79.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khajuria</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mahapatra</surname>
                      <given-names>D.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model</article-title>
                  <source>Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci.</source>
                  <year>2015</year>
                  <volume>66</volume>
                  <fpage>173</fpage>
                  <lpage>183</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejps.2014.10.015</pub-id>
                </element-citation>
              </ref>
              <ref id="B80-ijms-23-08650">
                <label>80.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khajuria</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Disha</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Vasireddi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mahapatra</surname>
                      <given-names>D.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis</article-title>
                  <source>Mater. Sci. Eng. C Mater. Biol. Appl.</source>
                  <year>2016</year>
                  <volume>63</volume>
                  <fpage>78</fpage>
                  <lpage>87</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.msec.2016.02.062</pub-id>
                  <pub-id pub-id-type="pmid">27040198</pub-id>
                </element-citation>
              </ref>
              <ref id="B81-ijms-23-08650">
                <label>81.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khajuria</surname>
                      <given-names>D.K.</given-names>
                    </name>
                    <name>
                      <surname>Vasireddi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Trebbin</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Karasik</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Razdan</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Novel therapeutic intervention for osteoporosis prepared with strontium hydroxyapatite and zoledronic acid: In vitro and pharmacodynamic evaluation</article-title>
                  <source>Mater. Sci. Eng. C Mater. Biol. Appl.</source>
                  <year>2017</year>
                  <volume>71</volume>
                  <fpage>698</fpage>
                  <lpage>708</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.msec.2016.10.066</pub-id>
                  <pub-id pub-id-type="pmid">27987763</pub-id>
                </element-citation>
              </ref>
              <ref id="B82-ijms-23-08650">
                <label>82.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jilka</surname>
                      <given-names>R.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>The relevance of mouse models for investigating age-related bone loss in humans</article-title>
                  <source>J. Gerontol. A Biol. Sci. Med. Sci.</source>
                  <year>2013</year>
                  <volume>68</volume>
                  <fpage>1209</fpage>
                  <lpage>1217</lpage>
                  <pub-id pub-id-type="doi">10.1093/gerona/glt046</pub-id>
                  <?supplied-pmid 23689830?>
                  <pub-id pub-id-type="pmid">23689830</pub-id>
                </element-citation>
              </ref>
              <ref id="B83-ijms-23-08650">
                <label>83.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Finkelstein</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Brockwell</surname>
                      <given-names>S.E.</given-names>
                    </name>
                    <name>
                      <surname>Mehta</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Greendale</surname>
                      <given-names>G.A.</given-names>
                    </name>
                    <name>
                      <surname>Sowers</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Ettinger</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Lo</surname>
                      <given-names>J.C.</given-names>
                    </name>
                    <name>
                      <surname>Johnston</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Cauley</surname>
                      <given-names>J.A.</given-names>
                    </name>
                    <name>
                      <surname>Danielson</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Bone mineral density changes during the menopause transition in a multiethnic cohort of women</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2008</year>
                  <volume>93</volume>
                  <fpage>861</fpage>
                  <lpage>868</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2007-1876</pub-id>
                  <?supplied-pmid 18160467?>
                  <pub-id pub-id-type="pmid">18160467</pub-id>
                </element-citation>
              </ref>
              <ref id="B84-ijms-23-08650">
                <label>84.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Guthrie</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Ebeling</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Hopper</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Barrett-Connor</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Dennerstein</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Dudley</surname>
                      <given-names>E.C.</given-names>
                    </name>
                    <name>
                      <surname>Burger</surname>
                      <given-names>H.G.</given-names>
                    </name>
                    <name>
                      <surname>Wark</surname>
                      <given-names>J.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>A prospective study of bone loss in menopausal Australian-born women</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>1998</year>
                  <volume>8</volume>
                  <fpage>282</fpage>
                  <lpage>290</lpage>
                  <pub-id pub-id-type="doi">10.1007/s001980050066</pub-id>
                  <?supplied-pmid 9797914?>
                  <pub-id pub-id-type="pmid">9797914</pub-id>
                </element-citation>
              </ref>
              <ref id="B85-ijms-23-08650">
                <label>85.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Keshawarz</surname>
                      <given-names>N.M.</given-names>
                    </name>
                    <name>
                      <surname>Recker</surname>
                      <given-names>R.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis</article-title>
                  <source>Metab. Bone Dis. Relat. Res.</source>
                  <year>1984</year>
                  <volume>5</volume>
                  <fpage>223</fpage>
                  <lpage>228</lpage>
                  <pub-id pub-id-type="doi">10.1016/0221-8747(84)90063-8</pub-id>
                  <pub-id pub-id-type="pmid">6493034</pub-id>
                </element-citation>
              </ref>
              <ref id="B86-ijms-23-08650">
                <label>86.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Akesson</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ljunghall</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Jonsson</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Sernbo</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Johnell</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Gärdsell</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Obrant</surname>
                      <given-names>K.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>1995</year>
                  <volume>10</volume>
                  <fpage>1823</fpage>
                  <lpage>1829</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.5650101127</pub-id>
                  <pub-id pub-id-type="pmid">8592961</pub-id>
                </element-citation>
              </ref>
              <ref id="B87-ijms-23-08650">
                <label>87.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Garnero</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Hausherr</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Chapuy</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Marcelli</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Grandjean</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Muller</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Cormier</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Bréart</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Meunier</surname>
                      <given-names>P.J.</given-names>
                    </name>
                    <name>
                      <surname>Delmas</surname>
                      <given-names>P.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>1996</year>
                  <volume>11</volume>
                  <fpage>1531</fpage>
                  <lpage>1538</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.5650111021</pub-id>
                  <pub-id pub-id-type="pmid">8889854</pub-id>
                </element-citation>
              </ref>
              <ref id="B88-ijms-23-08650">
                <label>88.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Garnero</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Shih</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>Gineyts</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Karpf</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Delmas</surname>
                      <given-names>P.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>1994</year>
                  <volume>79</volume>
                  <fpage>1693</fpage>
                  <lpage>1700</lpage>
                  <pub-id pub-id-type="doi">10.1210/jcem.79.6.7989477</pub-id>
                  <?supplied-pmid 7989477?>
                  <pub-id pub-id-type="pmid">7989477</pub-id>
                </element-citation>
              </ref>
              <ref id="B89-ijms-23-08650">
                <label>89.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Delmas</surname>
                      <given-names>P.D.</given-names>
                    </name>
                    <name>
                      <surname>Eastell</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Garnero</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Seibel</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Stepan</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>2000</year>
                  <volume>11</volume>
                  <issue>(Suppl. S6)</issue>
                  <fpage>S2</fpage>
                  <lpage>S17</lpage>
                  <pub-id pub-id-type="doi">10.1007/s001980070002</pub-id>
                  <?supplied-pmid 11193237?>
                  <pub-id pub-id-type="pmid">11193237</pub-id>
                </element-citation>
              </ref>
              <ref id="B90-ijms-23-08650">
                <label>90.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fabre</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Funck-Brentano</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Cohen-Solal</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases</article-title>
                  <source>J. Clin. Med.</source>
                  <year>2020</year>
                  <volume>9</volume>
                  <elocation-id>3439</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/jcm9113439</pub-id>
                </element-citation>
              </ref>
              <ref id="B91-ijms-23-08650">
                <label>91.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chan</surname>
                      <given-names>C.Y.</given-names>
                    </name>
                    <name>
                      <surname>Subramaniam</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Mohamed</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Muhammad</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Ramli</surname>
                      <given-names>F.F.</given-names>
                    </name>
                    <name>
                      <surname>Ima-Nirwana</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chin</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Circulating Biomarkers Related to Osteocyte and Calcium Homeostasis Between Postmenopausal Women with and without Osteoporosis</article-title>
                  <source>Endocr. Metab. Immune Disord. Drug Targets</source>
                  <year>2021</year>
                  <volume>21</volume>
                  <fpage>2273</fpage>
                  <lpage>2280</lpage>
                  <pub-id pub-id-type="doi">10.2174/1871530321666210809154456</pub-id>
                  <pub-id pub-id-type="pmid">34370656</pub-id>
                </element-citation>
              </ref>
              <ref id="B92-ijms-23-08650">
                <label>92.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>X.J.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Y.P.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>F.R.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Shuai</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.G.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>M.X.</given-names>
                    </name>
                  </person-group>
                  <article-title>Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis</article-title>
                  <source>Chin. Med. J.</source>
                  <year>2013</year>
                  <volume>126</volume>
                  <fpage>2480</fpage>
                  <lpage>2484</lpage>
                  <pub-id pub-id-type="pmid">23823821</pub-id>
                </element-citation>
              </ref>
              <ref id="B93-ijms-23-08650">
                <label>93.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Jing</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of estrogen deficiency on the proliferation and osteogenic differentiation potential of mandibular bone marrow stromal cells</article-title>
                  <source>Zhonghua Kou Qiang Yi Xue Za Zhi</source>
                  <year>2014</year>
                  <volume>49</volume>
                  <fpage>619</fpage>
                  <lpage>624</lpage>
                  <pub-id pub-id-type="pmid">25567716</pub-id>
                </element-citation>
              </ref>
              <ref id="B94-ijms-23-08650">
                <label>94.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Schiavi</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Fodera</surname>
                      <given-names>D.M.</given-names>
                    </name>
                    <name>
                      <surname>Brennan</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>McNamara</surname>
                      <given-names>L.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro</article-title>
                  <source>Exp. Cell Res.</source>
                  <year>2021</year>
                  <volume>408</volume>
                  <fpage>112814</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.yexcr.2021.112814</pub-id>
                  <pub-id pub-id-type="pmid">34492267</pub-id>
                </element-citation>
              </ref>
              <ref id="B95-ijms-23-08650">
                <label>95.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Stolzenberg</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Belavý</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Beller</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Armbrecht</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Semler</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Felsenberg</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone strength and density via pQCT in post-menopausal osteopenic women after 9 months resistive exercise with whole body vibration or proprioceptive exercise</article-title>
                  <source>J. Musculoskelet Neuronal Interact.</source>
                  <year>2013</year>
                  <volume>13</volume>
                  <fpage>66</fpage>
                  <lpage>76</lpage>
                  <pub-id pub-id-type="pmid">23445916</pub-id>
                </element-citation>
              </ref>
              <ref id="B96-ijms-23-08650">
                <label>96.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kerr</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Morton</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Dick</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Prince</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise effects on bone mass in postmenopausal women are site-specific and load-dependent</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>1996</year>
                  <volume>11</volume>
                  <fpage>218</fpage>
                  <lpage>225</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.5650110211</pub-id>
                  <?supplied-pmid 8822346?>
                  <pub-id pub-id-type="pmid">8822346</pub-id>
                </element-citation>
              </ref>
              <ref id="B97-ijms-23-08650">
                <label>97.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nelson</surname>
                      <given-names>M.E.</given-names>
                    </name>
                    <name>
                      <surname>Fisher</surname>
                      <given-names>E.C.</given-names>
                    </name>
                    <name>
                      <surname>Dilmanian</surname>
                      <given-names>F.A.</given-names>
                    </name>
                    <name>
                      <surname>Dallal</surname>
                      <given-names>G.E.</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>W.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>A 1-y walking program and increased dietary calcium in postmenopausal women: Effects on bone</article-title>
                  <source>Am. J. Clin. Nutr.</source>
                  <year>1991</year>
                  <volume>53</volume>
                  <fpage>1304</fpage>
                  <lpage>1311</lpage>
                  <pub-id pub-id-type="doi">10.1093/ajcn/53.5.1304</pub-id>
                  <pub-id pub-id-type="pmid">2021138</pub-id>
                </element-citation>
              </ref>
              <ref id="B98-ijms-23-08650">
                <label>98.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bloomfield</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>N.I.</given-names>
                    </name>
                    <name>
                      <surname>Lamb</surname>
                      <given-names>D.R.</given-names>
                    </name>
                    <name>
                      <surname>Jackson</surname>
                      <given-names>R.D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Non-weightbearing exercise may increase lumbar spine bone mineral density in healthy postmenopausal women</article-title>
                  <source>Am. J. Phys. Med. Rehabil.</source>
                  <year>1993</year>
                  <volume>72</volume>
                  <fpage>204</fpage>
                  <lpage>209</lpage>
                  <pub-id pub-id-type="doi">10.1097/00002060-199308000-00006</pub-id>
                  <?supplied-pmid 8363815?>
                  <pub-id pub-id-type="pmid">8363815</pub-id>
                </element-citation>
              </ref>
              <ref id="B99-ijms-23-08650">
                <label>99.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sanad</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Ellakwa</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Desouky</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis</article-title>
                  <source>Climacteric</source>
                  <year>2011</year>
                  <volume>14</volume>
                  <fpage>369</fpage>
                  <lpage>377</lpage>
                  <pub-id pub-id-type="doi">10.3109/13697137.2010.537408</pub-id>
                  <?supplied-pmid 21254911?>
                  <pub-id pub-id-type="pmid">21254911</pub-id>
                </element-citation>
              </ref>
              <ref id="B100-ijms-23-08650">
                <label>100.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nakamura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Matsumoto</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Sugimoto</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hosoi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Miki</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Gorai</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Yoshikawa</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sone</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Clinical Trials Express: Fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: Denosumab fracture intervention randomized placebo controlled trial (DIRECT)</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2014</year>
                  <volume>99</volume>
                  <fpage>2599</fpage>
                  <lpage>2607</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2013-4175</pub-id>
                  <pub-id pub-id-type="pmid">24646104</pub-id>
                </element-citation>
              </ref>
              <ref id="B101-ijms-23-08650">
                <label>101.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kendler</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Palacios</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Cox</surname>
                      <given-names>D.A.</given-names>
                    </name>
                    <name>
                      <surname>Stock</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Alam</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Dowsett</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Zanchetta</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Arzoxifene versus raloxifene: Effect on bone and safety parameters in postmenopausal women with osteoporosis</article-title>
                  <source>Osteoporos. Int.</source>
                  <year>2012</year>
                  <volume>23</volume>
                  <fpage>1091</fpage>
                  <lpage>1101</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00198-011-1587-0</pub-id>
                  <pub-id pub-id-type="pmid">21374068</pub-id>
                </element-citation>
              </ref>
              <ref id="B102-ijms-23-08650">
                <label>102.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bone</surname>
                      <given-names>H.G.</given-names>
                    </name>
                    <name>
                      <surname>Wagman</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Brandi</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>J.P.</given-names>
                    </name>
                    <name>
                      <surname>Chapurlat</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Cummings</surname>
                      <given-names>S.R.</given-names>
                    </name>
                    <name>
                      <surname>Czerwiński</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Fahrleitner-Pammer</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Kendler</surname>
                      <given-names>D.L.</given-names>
                    </name>
                    <name>
                      <surname>Lippuner</surname>
                      <given-names>K.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>10 years of denosumab treatment in postmenopausal women with osteoporosis: Results from the phase 3 randomised FREEDOM trial and open-label extension</article-title>
                  <source>Lancet Diabetes Endocrinol.</source>
                  <year>2017</year>
                  <volume>5</volume>
                  <fpage>513</fpage>
                  <lpage>523</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2213-8587(17)30138-9</pub-id>
                  <pub-id pub-id-type="pmid">28546097</pub-id>
                </element-citation>
              </ref>
              <ref id="B103-ijms-23-08650">
                <label>103.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tsai</surname>
                      <given-names>J.N.</given-names>
                    </name>
                    <name>
                      <surname>Uihlein</surname>
                      <given-names>A.V.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Kumbhani</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Siwila-Sackman</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>McKay</surname>
                      <given-names>E.A.</given-names>
                    </name>
                    <name>
                      <surname>Burnett-Bowie</surname>
                      <given-names>S.A.</given-names>
                    </name>
                    <name>
                      <surname>Neer</surname>
                      <given-names>R.M.</given-names>
                    </name>
                    <name>
                      <surname>Leder</surname>
                      <given-names>B.Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: The DATA study randomised trial</article-title>
                  <source>Lancet</source>
                  <year>2013</year>
                  <volume>382</volume>
                  <fpage>50</fpage>
                  <lpage>56</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60856-9</pub-id>
                  <pub-id pub-id-type="pmid">23683600</pub-id>
                </element-citation>
              </ref>
              <ref id="B104-ijms-23-08650">
                <label>104.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gossiel</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Scott</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Paggiosi</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Naylor</surname>
                      <given-names>K.E.</given-names>
                    </name>
                    <name>
                      <surname>McCloskey</surname>
                      <given-names>E.V.</given-names>
                    </name>
                    <name>
                      <surname>Peel</surname>
                      <given-names>N.F.A.</given-names>
                    </name>
                    <name>
                      <surname>Walsh</surname>
                      <given-names>J.S.</given-names>
                    </name>
                    <name>
                      <surname>Eastell</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effect of Teriparatide Treatment on Circulating Periostin and Its Relationship to Regulators of Bone Formation and BMD in Postmenopausal Women With Osteoporosis</article-title>
                  <source>J. Clin. Endocrinol. Metab.</source>
                  <year>2018</year>
                  <volume>103</volume>
                  <fpage>1302</fpage>
                  <lpage>1309</lpage>
                  <pub-id pub-id-type="doi">10.1210/jc.2017-00283</pub-id>
                  <pub-id pub-id-type="pmid">29365099</pub-id>
                </element-citation>
              </ref>
              <ref id="B105-ijms-23-08650">
                <label>105.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Allen</surname>
                      <given-names>M.R.</given-names>
                    </name>
                    <name>
                      <surname>Burr</surname>
                      <given-names>D.B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don’t know</article-title>
                  <source>Bone</source>
                  <year>2011</year>
                  <volume>49</volume>
                  <fpage>56</fpage>
                  <lpage>65</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2010.10.159</pub-id>
                  <pub-id pub-id-type="pmid">20955825</pub-id>
                </element-citation>
              </ref>
              <ref id="B106-ijms-23-08650">
                <label>106.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Qaisi</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hargett</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Loeb</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Caloss</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Denosumab Related Osteonecrosis of the Jaw with Spontaneous Necrosis of the Soft Palate: Report of a Life Threatening Case</article-title>
                  <source>Case Rep. Dent.</source>
                  <year>2016</year>
                  <volume>2016</volume>
                  <fpage>5070187</fpage>
                  <pub-id pub-id-type="doi">10.1155/2016/5070187</pub-id>
                  <pub-id pub-id-type="pmid">27648313</pub-id>
                </element-citation>
              </ref>
              <ref id="B107-ijms-23-08650">
                <label>107.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Diz</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>López-Cedrún</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Arenaz</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Scully</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Denosumab-related osteonecrosis of the jaw</article-title>
                  <source>J. Am. Dent. Assoc.</source>
                  <year>2012</year>
                  <volume>143</volume>
                  <fpage>981</fpage>
                  <lpage>984</lpage>
                  <pub-id pub-id-type="doi">10.14219/jada.archive.2012.0323</pub-id>
                  <?supplied-pmid 22942143?>
                  <pub-id pub-id-type="pmid">22942143</pub-id>
                </element-citation>
              </ref>
              <ref id="B108-ijms-23-08650">
                <label>108.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hamadeh</surname>
                      <given-names>I.S.</given-names>
                    </name>
                    <name>
                      <surname>Ngwa</surname>
                      <given-names>B.A.</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Drug induced osteonecrosis of the jaw</article-title>
                  <source>Cancer Treat. Rev.</source>
                  <year>2015</year>
                  <volume>41</volume>
                  <fpage>455</fpage>
                  <lpage>464</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ctrv.2015.04.007</pub-id>
                  <?supplied-pmid 25913713?>
                  <pub-id pub-id-type="pmid">25913713</pub-id>
                </element-citation>
              </ref>
              <ref id="B109-ijms-23-08650">
                <label>109.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Komori</surname>
                      <given-names>T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Animal models for osteoporosis</article-title>
                  <source>Eur. J. Pharmacol.</source>
                  <year>2015</year>
                  <volume>759</volume>
                  <fpage>287</fpage>
                  <lpage>294</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.ejphar.2015.03.028</pub-id>
                  <?supplied-pmid 25814262?>
                  <pub-id pub-id-type="pmid">25814262</pub-id>
                </element-citation>
              </ref>
              <ref id="B110-ijms-23-08650">
                <label>110.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Srinivasan</surname>
                      <given-names>V.</given-names>
                    </name>
                    <name>
                      <surname>Tao</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Boyce</surname>
                      <given-names>B.F.</given-names>
                    </name>
                    <name>
                      <surname>Ebetino</surname>
                      <given-names>F.H.</given-names>
                    </name>
                    <name>
                      <surname>Boeckman</surname>
                      <given-names>R.K.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Targeting Bortezomib to Bone Increases Its Bone Anabolic Activity and Reduces Systemic Adverse Effects in Mice</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2020</year>
                  <volume>35</volume>
                  <fpage>343</fpage>
                  <lpage>356</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.3889</pub-id>
                  <pub-id pub-id-type="pmid">31610066</pub-id>
                </element-citation>
              </ref>
              <ref id="B111-ijms-23-08650">
                <label>111.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>M.O.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Neupane</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.H.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation</article-title>
                  <source>J. Bone Miner. Metab.</source>
                  <year>2018</year>
                  <volume>36</volume>
                  <fpage>537</fpage>
                  <lpage>546</lpage>
                  <pub-id pub-id-type="doi">10.1007/s00774-017-0871-2</pub-id>
                  <pub-id pub-id-type="pmid">29027021</pub-id>
                </element-citation>
              </ref>
              <ref id="B112-ijms-23-08650">
                <label>112.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>K.W.</given-names>
                    </name>
                  </person-group>
                  <article-title>Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion</article-title>
                  <source>Oxid. Med. Cell Longev.</source>
                  <year>2019</year>
                  <volume>2019</volume>
                  <fpage>3503912</fpage>
                  <pub-id pub-id-type="doi">10.1155/2019/3503912</pub-id>
                  <?supplied-pmid 31275508?>
                  <pub-id pub-id-type="pmid">31275508</pub-id>
                </element-citation>
              </ref>
              <ref id="B113-ijms-23-08650">
                <label>113.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>He</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Su</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Wen</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparison of Necroptosis With Apoptosis for OVX-Induced Osteoporosis</article-title>
                  <source>Front. Mol. Biosci.</source>
                  <year>2021</year>
                  <volume>8</volume>
                  <fpage>790613</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmolb.2021.790613</pub-id>
                  <pub-id pub-id-type="pmid">35004853</pub-id>
                </element-citation>
              </ref>
              <ref id="B114-ijms-23-08650">
                <label>114.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kitazawa</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Kimble</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Vannice</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Kung</surname>
                      <given-names>V.T.</given-names>
                    </name>
                    <name>
                      <surname>Pacifici</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>1994</year>
                  <volume>94</volume>
                  <fpage>2397</fpage>
                  <lpage>2406</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI117606</pub-id>
                  <?supplied-pmid 7989596?>
                  <pub-id pub-id-type="pmid">7989596</pub-id>
                </element-citation>
              </ref>
              <ref id="B115-ijms-23-08650">
                <label>115.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Girasole</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Jilka</surname>
                      <given-names>R.L.</given-names>
                    </name>
                    <name>
                      <surname>Passeri</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Boswell</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Boder</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Williams</surname>
                      <given-names>D.C.</given-names>
                    </name>
                    <name>
                      <surname>Manolagas</surname>
                      <given-names>S.C.</given-names>
                    </name>
                  </person-group>
                  <article-title>17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>1992</year>
                  <volume>89</volume>
                  <fpage>883</fpage>
                  <lpage>891</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI115668</pub-id>
                  <?supplied-pmid 1541679?>
                  <pub-id pub-id-type="pmid">1541679</pub-id>
                </element-citation>
              </ref>
              <ref id="B116-ijms-23-08650">
                <label>116.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Littlewood</surname>
                      <given-names>A.J.</given-names>
                    </name>
                    <name>
                      <surname>Aarden</surname>
                      <given-names>L.A.</given-names>
                    </name>
                    <name>
                      <surname>Evans</surname>
                      <given-names>D.B.</given-names>
                    </name>
                    <name>
                      <surname>Russell</surname>
                      <given-names>R.G.</given-names>
                    </name>
                    <name>
                      <surname>Gowen</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Human osteoblastlike cells do not respond to interleukin-6</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>1991</year>
                  <volume>6</volume>
                  <fpage>141</fpage>
                  <lpage>148</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.5650060207</pub-id>
                  <?supplied-pmid 1709332?>
                  <pub-id pub-id-type="pmid">1709332</pub-id>
                </element-citation>
              </ref>
              <ref id="B117-ijms-23-08650">
                <label>117.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kimble</surname>
                      <given-names>R.B.</given-names>
                    </name>
                    <name>
                      <surname>Bain</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pacifici</surname>
                      <given-names>R.</given-names>
                    </name>
                  </person-group>
                  <article-title>The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>1997</year>
                  <volume>12</volume>
                  <fpage>935</fpage>
                  <lpage>941</lpage>
                  <pub-id pub-id-type="doi">10.1359/jbmr.1997.12.6.935</pub-id>
                  <?supplied-pmid 9169353?>
                  <pub-id pub-id-type="pmid">9169353</pub-id>
                </element-citation>
              </ref>
              <ref id="B118-ijms-23-08650">
                <label>118.</label>
                <element-citation publication-type="gov">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wotring</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evidence Report: Risk of Therapeutic Failure Due to Ineffectiveness of Medication</article-title>
                  <comment>Available online: <ext-link xlink:href="https://humanresearchroadmap.nasa.gov/Evidence/reports/Pharm.pdf" ext-link-type="uri">https://humanresearchroadmap.nasa.gov/Evidence/reports/Pharm.pdf</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2022-04-05">(accessed on 5 April 2022)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B119-ijms-23-08650">
                <label>119.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gandia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Saivin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Houin</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>The influence of weightlessness on pharmacokinetics</article-title>
                  <source>Fundam. Clin. Pharmacol.</source>
                  <year>2005</year>
                  <volume>19</volume>
                  <fpage>625</fpage>
                  <lpage>636</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1472-8206.2005.00374.x</pub-id>
                  <?supplied-pmid 16313274?>
                  <pub-id pub-id-type="pmid">16313274</pub-id>
                </element-citation>
              </ref>
              <ref id="B120-ijms-23-08650">
                <label>120.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gandia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Bareille</surname>
                      <given-names>M.P.</given-names>
                    </name>
                    <name>
                      <surname>Saivin</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Le-Traon</surname>
                      <given-names>A.P.</given-names>
                    </name>
                    <name>
                      <surname>Lavit</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Guell</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Houin</surname>
                      <given-names>G.</given-names>
                    </name>
                  </person-group>
                  <article-title>Influence of simulated weightlessness on the oral pharmacokinetics of acetaminophen as a gastric emptying probe in man: A plasma and a saliva study</article-title>
                  <source>J. Clin. Pharmacol.</source>
                  <year>2003</year>
                  <volume>43</volume>
                  <fpage>1235</fpage>
                  <lpage>1243</lpage>
                  <pub-id pub-id-type="doi">10.1177/0091270003257229</pub-id>
                  <pub-id pub-id-type="pmid">14551178</pub-id>
                </element-citation>
              </ref>
              <ref id="B121-ijms-23-08650">
                <label>121.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Merrill</surname>
                      <given-names>A.H.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>LaRocque</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Mullins</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Morgan</surname>
                      <given-names>E.T.</given-names>
                    </name>
                    <name>
                      <surname>Hargrove</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Bonkovsky</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Popova</surname>
                      <given-names>I.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Differences in glycogen, lipids, and enzymes in livers from rats flown on COSMOS 2044</article-title>
                  <source>J. Appl. Physiol.</source>
                  <year>1992</year>
                  <volume>73</volume>
                  <fpage>142S</fpage>
                  <lpage>147S</lpage>
                  <pub-id pub-id-type="doi">10.1152/jappl.1992.73.2.S142</pub-id>
                  <?supplied-pmid 1526942?>
                  <pub-id pub-id-type="pmid">1526942</pub-id>
                </element-citation>
              </ref>
              <ref id="B122-ijms-23-08650">
                <label>122.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Merrill</surname>
                      <given-names>A.H.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Hoel</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Mullins</surname>
                      <given-names>R.E.</given-names>
                    </name>
                    <name>
                      <surname>Hargrove</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D.P.</given-names>
                    </name>
                    <name>
                      <surname>Popova</surname>
                      <given-names>I.A.</given-names>
                    </name>
                  </person-group>
                  <article-title>Altered carbohydrate, lipid, and xenobiotic metabolism by liver from rats flown on Cosmos 1887</article-title>
                  <source>FASEB J.</source>
                  <year>1990</year>
                  <volume>4</volume>
                  <fpage>95</fpage>
                  <lpage>100</lpage>
                  <pub-id pub-id-type="doi">10.1096/fasebj.4.1.2295381</pub-id>
                  <pub-id pub-id-type="pmid">2295381</pub-id>
                </element-citation>
              </ref>
              <ref id="B123-ijms-23-08650">
                <label>123.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Merrill</surname>
                      <given-names>A.H.</given-names>
                      <suffix>Jr.</suffix>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Jones</surname>
                      <given-names>D.P.</given-names>
                    </name>
                    <name>
                      <surname>Hargrove</surname>
                      <given-names>J.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hepatic function in rats after spaceflight: Effects on lipids, glycogen, and enzymes</article-title>
                  <source>Am. J. Physiol.</source>
                  <year>1987</year>
                  <volume>252</volume>
                  <fpage>R222</fpage>
                  <lpage>R226</lpage>
                  <pub-id pub-id-type="doi">10.1152/ajpregu.1987.252.2.R222</pub-id>
                  <?supplied-pmid 3812760?>
                  <pub-id pub-id-type="pmid">3812760</pub-id>
                </element-citation>
              </ref>
              <ref id="B124-ijms-23-08650">
                <label>124.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Luo</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Qiao</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zeng</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Nie</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>A</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Irisin ameliorates bone loss in ovariectomized mice</article-title>
                  <source>Climacteric</source>
                  <year>2020</year>
                  <volume>23</volume>
                  <fpage>496</fpage>
                  <lpage>504</lpage>
                  <pub-id pub-id-type="doi">10.1080/13697137.2020.1745768</pub-id>
                  <pub-id pub-id-type="pmid">32319323</pub-id>
                </element-citation>
              </ref>
              <ref id="B125-ijms-23-08650">
                <label>125.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Morgan</surname>
                      <given-names>E.N.</given-names>
                    </name>
                    <name>
                      <surname>Alsharidah</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Mousa</surname>
                      <given-names>A.M.</given-names>
                    </name>
                    <name>
                      <surname>Edrees</surname>
                      <given-names>H.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Irisin Has a Protective Role against Osteoporosis in Ovariectomized Rats</article-title>
                  <source>Biomed. Res. Int.</source>
                  <year>2021</year>
                  <volume>2021</volume>
                  <fpage>5570229</fpage>
                  <pub-id pub-id-type="doi">10.1155/2021/5570229</pub-id>
                  <?supplied-pmid 33997010?>
                  <pub-id pub-id-type="pmid">33997010</pub-id>
                </element-citation>
              </ref>
              <ref id="B126-ijms-23-08650">
                <label>126.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Wai-Chee Kung</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Pheng</surname>
                      <given-names>C.S.</given-names>
                    </name>
                    <name>
                      <surname>Zhu</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Z.L.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Y.Y.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Meng</surname>
                      <given-names>X.W.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>M.L.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>L.P.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Efficacy and safety of 2 g/day of strontium ranelate in Asian women with postmenopausal osteoporosis</article-title>
                  <source>Bone</source>
                  <year>2009</year>
                  <volume>45</volume>
                  <fpage>460</fpage>
                  <lpage>465</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2009.05.014</pub-id>
                  <?supplied-pmid 19464401?>
                  <pub-id pub-id-type="pmid">19464401</pub-id>
                </element-citation>
              </ref>
              <ref id="B127-ijms-23-08650">
                <label>127.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Reginster</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Bruyère</surname>
                      <given-names>O.</given-names>
                    </name>
                    <name>
                      <surname>Sawicki</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Roces-Varela</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Fardellone</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Roberts</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Devogelaer</surname>
                      <given-names>J.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years</article-title>
                  <source>Bone</source>
                  <year>2009</year>
                  <volume>45</volume>
                  <fpage>1059</fpage>
                  <lpage>1064</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2009.08.004</pub-id>
                  <pub-id pub-id-type="pmid">19679207</pub-id>
                </element-citation>
              </ref>
              <ref id="B128-ijms-23-08650">
                <label>128.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Talaulikar</surname>
                      <given-names>V.S.</given-names>
                    </name>
                    <name>
                      <surname>Chambers</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Manyonda</surname>
                      <given-names>I.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exploiting the antioxidant potential of a common vitamin: Could vitamin C prevent postmenopausal osteoporosis?</article-title>
                  <source>J. Obstet. Gynaecol. Res.</source>
                  <year>2012</year>
                  <volume>38</volume>
                  <fpage>253</fpage>
                  <lpage>257</lpage>
                  <pub-id pub-id-type="doi">10.1111/j.1447-0756.2011.01629.x</pub-id>
                  <pub-id pub-id-type="pmid">21827580</pub-id>
                </element-citation>
              </ref>
              <ref id="B129-ijms-23-08650">
                <label>129.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wong</surname>
                      <given-names>R.H.</given-names>
                    </name>
                    <name>
                      <surname>Thaung Zaw</surname>
                      <given-names>J.J.</given-names>
                    </name>
                    <name>
                      <surname>Xian</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Howe</surname>
                      <given-names>P.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2020</year>
                  <volume>35</volume>
                  <fpage>2121</fpage>
                  <lpage>2131</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.4115</pub-id>
                  <pub-id pub-id-type="pmid">32564438</pub-id>
                </element-citation>
              </ref>
              <ref id="B130-ijms-23-08650">
                <label>130.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khanizadeh</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Rahmani</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Asadollahi</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ahmadi</surname>
                      <given-names>M.R.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Combination therapy of curcumin and alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis</article-title>
                  <source>Arch. Endocrinol. Metab.</source>
                  <year>2018</year>
                  <volume>62</volume>
                  <fpage>438</fpage>
                  <lpage>445</lpage>
                  <pub-id pub-id-type="doi">10.20945/2359-3997000000060</pub-id>
                  <pub-id pub-id-type="pmid">30304108</pub-id>
                </element-citation>
              </ref>
              <ref id="B131-ijms-23-08650">
                <label>131.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fournier</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Harrison</surname>
                      <given-names>R.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Strategies for studying bone loss in microgravity</article-title>
                  <source>Reach</source>
                  <year>2020</year>
                  <volume>17</volume>
                  <fpage>100036</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.reach.2020.100036</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig position="float" id="ijms-23-08650-f001">
              <label>Figure 1</label>
              <caption>
                <p>The treatment of menopausal osteoporosis. Abbreviations: RANKL, receptor activator of nuclear factor κβ ligand; SERMS, selective estrogen receptor modulator; Scl-Ab, antisclerostin antibody [<xref rid="B10-ijms-23-08650" ref-type="bibr">10</xref>,<xref rid="B16-ijms-23-08650" ref-type="bibr">16</xref>,<xref rid="B19-ijms-23-08650" ref-type="bibr">19</xref>]. The insert shows the Scl-Ab’s dual mode of action in more detail. Created with <uri>BioRender.com</uri> (accessed on 27 July 2022).</p>
              </caption>
              <graphic xlink:href="ijms-23-08650-g001" position="float"/>
            </fig>
            <fig position="float" id="ijms-23-08650-f002">
              <label>Figure 2</label>
              <caption>
                <p>Mechanisms of microgravity (µ<italic toggle="yes">g</italic>)-induced bone loss: µ<italic toggle="yes">g</italic> releases calcium from bone, which suppresses the parathyroid hormone (PTH). Afterward, the suppressed PTH then lowers the circulating 1,25-dihydroxyvitamin D. This leads to decreased calcium absorption [<xref rid="B24-ijms-23-08650" ref-type="bibr">24</xref>,<xref rid="B26-ijms-23-08650" ref-type="bibr">26</xref>,<xref rid="B27-ijms-23-08650" ref-type="bibr">27</xref>,<xref rid="B28-ijms-23-08650" ref-type="bibr">28</xref>]. Additionally, osteoblast function is impaired, and osteocyte apoptosis is increased [<xref rid="B5-ijms-23-08650" ref-type="bibr">5</xref>,<xref rid="B32-ijms-23-08650" ref-type="bibr">32</xref>]. This results in unchanged or decreased bone formation and increased bone resorption, which leads to bone loss [<xref rid="B22-ijms-23-08650" ref-type="bibr">22</xref>,<xref rid="B23-ijms-23-08650" ref-type="bibr">23</xref>,<xref rid="B24-ijms-23-08650" ref-type="bibr">24</xref>]. Created with <uri>BioRender.com</uri> (accessed on 27 July 2022).</p>
              </caption>
              <graphic xlink:href="ijms-23-08650-g002" position="float"/>
            </fig>
            <fig position="float" id="ijms-23-08650-f003">
              <label>Figure 3</label>
              <caption>
                <p>Search terms in PubMed.</p>
              </caption>
              <graphic xlink:href="ijms-23-08650-g003" position="float"/>
            </fig>
            <fig position="float" id="ijms-23-08650-f004">
              <label>Figure 4</label>
              <caption>
                <p>Flowchart of study selection.</p>
              </caption>
              <graphic xlink:href="ijms-23-08650-g004" position="float"/>
            </fig>
            <table-wrap position="float" id="ijms-23-08650-t001">
              <object-id pub-id-type="pii">ijms-23-08650-t001_Table 1</object-id>
              <label>Table 1</label>
              <caption>
                <p>The mechanisms of µ<italic toggle="yes">g</italic>-related changes in bone density.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Publication Year</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Real microgravity in humans</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bilancio et al., 2019 [<xref rid="B42-ijms-23-08650" ref-type="bibr">42</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 male (52 years) and 1 female (37 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 months on ISS</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to BSL: Decrease of 0.9 to 1.4% in total BMD; Increase of 27 to 116% in urine calcium/creatinine ratio.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Burkhart et al., 2020 [<xref rid="B43-ijms-23-08650" ref-type="bibr">43</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 female and 16 males (45 ± 4 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4–7 months on ISS</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Between 4.6% and 6.1% decline in vertebral volumetric BMD (<italic toggle="yes">p</italic> &lt; 0.05) compared to preflight.<break/>Vertebral volumetric BMD decreased 1% and lumbar spine BMD decreased 0.5% per month.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sibonga et al., 2020 [<xref rid="B44-ijms-23-08650" ref-type="bibr">44</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 humans (gender N/A, 48 ± 5 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">157 ± 21 days on ISS</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 of 10 astronauts had an incomplete recovery of BMD 1 year after return to Earth, which persisted in 4 of 5 astronauts after 2 years compared to BSL.</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Real microgravity in animals</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berg-Johansen et al., 2016 [<xref rid="B45-ijms-23-08650" ref-type="bibr">45</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 male C57BL/6 mice (19–20 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 6): 30 days in low Earth orbit<break/>CG (<italic toggle="yes">n</italic> = 8): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG showed 20% reduced BV/TV (<italic toggle="yes">p</italic> &lt; 0.05), 18% reduced BMD (<italic toggle="yes">p</italic> &lt; 0.05), and 14% reduced trabecular thickness (<italic toggle="yes">p</italic> = 0.001) compared to CG. No significant difference in the trabecular number or trabecular spacing.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gerbaix et al., 2017 [<xref rid="B46-ijms-23-08650" ref-type="bibr">46</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 C57/BL6 male mice (2 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 10): 30 days in space<break/>CG (<italic toggle="yes">n</italic> = 12): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG decreased femur BV 64% and vertebrae BV 35.7%. SG increased bone resorption 140% and empty lacunae 344%. No bone recovery in SG 8 days after landing despite normalized OC activity. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chatani et al., 2016 [<xref rid="B47-ijms-23-08650" ref-type="bibr">47</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Medaka fish larvae in stage 39 </td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 3–9, depending on the anaylsis): 8 days on the ISS<break/>CG (<italic toggle="yes">n</italic> = 3–16, depending on the anaylsis): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG had significantly enhanced osterix, osteocalcin, TRAP5, and matrix metallopeptidase-9.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Von Kroge et al., 2021 [<xref rid="B48-ijms-23-08650" ref-type="bibr">48</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C57BL/6N male mice (8–9 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 5): 4 weeks in space <break/>CG (<italic toggle="yes">n</italic> = 5): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">After 4 weeks in space, BV/TV, cortical thickness, trabecular number, and thickness significantly decreased. This bone loss was only recovered in trabecular bone, and not in cortical thickness.</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated microgravity in humans</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bonnefoy et al., 2022 [<xref rid="B49-ijms-23-08650" ref-type="bibr">49</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 male (34 ± 8 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 60 days HDBR + antioxidant<break/>CG: 60 days HDBR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to BSL: Decreased bone density of 1.4% (<italic toggle="yes">p</italic> &lt; 0.0001) and BV/TV of 1% (<italic toggle="yes">p</italic> &lt; 0.05). </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bemben et al., 2021 [<xref rid="B50-ijms-23-08650" ref-type="bibr">50</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 males and 5 females (25–50 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 d HDBR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to BSL: Increase in sclerostin, TRAP5, P1NP, and calcium. Decrease in total hip BMD and PTH. Women had a greater decrease in total hip BMD and increase in TRAP5 than men.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Buehlmeier et al., 2017 [<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 males (SG1 + SG2 ~60 years, SG3 ~23 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 8): 14 days bed rest<break/>SG2 (<italic toggle="yes">n</italic> = 8): 14 days bed rest + CD<break/>SG3 (<italic toggle="yes">n</italic> = 7): 14 days bed rest</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urinary N-telopeptide of type I collagen (<italic toggle="yes">p</italic> &lt; 0.05), urinary C-telopeptide of type I collagen (<italic toggle="yes">p</italic> = N/A), and sclerostin (<italic toggle="yes">p</italic> &lt; 0.05) increased during bed rest in all groups compared to BSL.</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated</bold>
                      <bold>microgravity in animals</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cabahug-Zuckerman et al., 2016 [<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 C57BL/6J male mice (4 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 6): 14 days HLU<break/>SG2 (<italic toggle="yes">n</italic> = 6): 14 days HLU + PC-I<break/>SG3 (<italic toggle="yes">n</italic> = 6): PC-I<break/>CG (<italic toggle="yes">n</italic> = 6): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">After 5 days: Increased RANKL-producing osteocytes and osteocyte apoptosis yjtrrfold in cortical bone and fourfold in trabecular SG1 compared to CG (<italic toggle="yes">p</italic> &lt; 0.05).<break/>After 14 days: Only the increased osteocyte apoptosis in trabecular bone and RANKL-producing osteocytes remained significantly elevated threefold in SG1 compared to CG. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chowdhury et al., 2016 [<xref rid="B53-ijms-23-08650" ref-type="bibr">53</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61 male rats (3–18 rats per SG and CG, age N/A)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 2 weeks HLU<break/>SG2: 2 weeks X-ray IR<break/>SG3: 2 weeks HLU + X-ray IR<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Significantly decreased BMD in distal femur and proximal tibia in SG1 and SG3 compared to CG (<italic toggle="yes">p</italic> &lt; 0.05), but BMD was not significantly decreased in SG2.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chen et al., 2021 [<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 C57/BL6 mice (2 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 6): 4 weeks HLU<break/>CG (<italic toggle="yes">n</italic> = 6): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MicroRNA-138-5p was upregulated during s-µ<italic toggle="yes">g</italic> in SG compared to CG (<italic toggle="yes">p</italic> &lt; 0.01).</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated</bold>
                      <bold>microgravity in vitro</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chen et al., 2021 [<xref rid="B54-ijms-23-08650" ref-type="bibr">54</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine pre-OB cells MC3T3-E1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 12 h RPM<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG: MicroRNA-138-5p decreased <italic toggle="yes">ALP</italic> 93.1% and <italic toggle="yes">collagen type 1 α-1</italic> 64.9% in SG (<italic toggle="yes">p</italic> &lt; 0.01). MicroRNA-138-5p decreased protein and mRNA expression of β-catenin in SG.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cazzaniga et al., 2016 [<xref rid="B55-ijms-23-08650" ref-type="bibr">55</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human bMSCs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 4 days RPM<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG show a significant upregulation of heat shock protein 60, heat-shock protein 70, superoxide dismutase 2 and cylclooxygenase 2, and a significant increase in RUNX2 and osterix compared to CG. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chen et al., 2016 [<xref rid="B56-ijms-23-08650" ref-type="bibr">56</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat bMSCs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 2 days clinostat<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinorotation significantly depolymerizes F-actin, and this hinders “transcriptional coactivator with PDZ-binding motif” nuclear. Furthermore, s-µ<italic toggle="yes">g</italic> inhibited ALP and RUNX2.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zhang et al., 2020 [<xref rid="B57-ijms-23-08650" ref-type="bibr">57</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine pre-OB MC3T3-E1</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 72 h clinorotation<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Expression of all but <italic toggle="yes">microRNA-30a</italic> in the microRNA-30 family is upregulated in s-µ<italic toggle="yes">g</italic>. This is negatively correlated with expression of <italic toggle="yes">RUNX2</italic>, osteocalcin and <italic toggle="yes">ALP</italic>, which decreased during s-µ<italic toggle="yes">g</italic>.</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Abbreviations: ISS: International Space Station, BSL: baseline, BMD; bone mineral density, N/A: not available, SG: study group, <italic toggle="yes">n</italic>: number of individuals, CG: control group, BV/TV: bone volume fraction, BV: bone volume OC: osteoclast, TRAP5: tartrate-resistant acid phosphatase 5b, HDBR: head-down tilt bed rest, P1NP: N-terminal propeptide of type 1 procollagen, PTH: parathyroid hormone, CD: cognitive training, and diet protein and alkaline, HLU: hindlimb-unloading, PC-I: pan-caspase inhibitor, RANKL: receptor activator of nuclear factor κβ ligand, IR: irradiation, s-µ<italic toggle="yes">g</italic>: simulated microgravity, OB: osteoblast, RPM: random positioning machine, ALP: alkaline phosphatase, bMSC: bone mesenchymal stem cell, RUNX2: RUNX family transcription factor 2.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="ijms-23-08650-t002">
              <object-id pub-id-type="pii">ijms-23-08650-t002_Table 2</object-id>
              <label>Table 2</label>
              <caption>
                <p>Possible CMs for µ<italic toggle="yes">g</italic>-induced bone loss and their effects.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author and Publication Year</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Intervention</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Real microgravity in vitro</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colucci et al., 2020 [<xref rid="B58-ijms-23-08650" ref-type="bibr">58</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">System 1: OC/OB<break/>System 2: OC/EC<break/>System 3: OC/OB/EC</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 14 days ISS + R-irisin<break/>SG2: 14 days ISS<break/>CG1: normal gravity<break/>CG2: normal gravity + R-irisin</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">R-irisin in SG1 prevented the downregulation of RUNX2, osterix, activating transcription factor 4, osteoprotegerin, and <italic toggle="yes">Collα1</italic> caused by microgravity.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cristofaro et al., 2019 [<xref rid="B59-ijms-23-08650" ref-type="bibr">59</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human bMSCs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 88 h ISS + SCHN<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCHN exhibited a protective effect in SG on the reduced ALP activity caused by microgravity compared to CG (<italic toggle="yes">p</italic> &lt; 0.05).</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated</bold>
                      <bold>microgravity in humans</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cavanagh et al., 2016 [<xref rid="B60-ijms-23-08650" ref-type="bibr">60</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 male and 6 female (30.2 ± 6.8 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 6): 84 days HDBR + LE<break/>CG (<italic toggle="yes">n</italic> = 6): 84 days HDBR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BMD in the intertrochanteric and total hip regions was decreased in CG, but not in SG compared to baseline. The BMD loss was higher in CG than in SG.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Belavý et al., 2016 [<xref rid="B61-ijms-23-08650" ref-type="bibr">61</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 males (32 ± 10.6 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 7): 60 days BR + vibration RE<break/>SG2 (<italic toggle="yes">n</italic> = 8): 60 days BR + RE<break/>CG (<italic toggle="yes">n</italic> = 9): 60 days BR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In SG1 and SG2 bone-specific ALP increased significantly more than in CG. SG1 also showed a greater proximal femur bone mineral content 6–24 months after BR compared to CG (<italic toggle="yes">p</italic> = 0.01). There was no significant difference on sclerostin and dickkopf-1 proteins.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gao et al., 2019 [<xref rid="B62-ijms-23-08650" ref-type="bibr">62</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 males and 4 females (30 ± 12 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-over study: 4 days of BR with either PBD or hospital diet separated by 30 days</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The PBD attenuated the increase of urinary N-telopeptide of type I collagen to 33% ± 20% from 89% ± 75% during hospital diet. PBD had no effect on BMD compared to hospital diet. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Buehlmeier et al., 2017 [<xref rid="B51-ijms-23-08650" ref-type="bibr">51</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 males (SG1 + SG2 ~60 years, SG3 ~23 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 8): 14 days BR<break/>SG2 (<italic toggle="yes">n</italic> = 8): 14 days BR + CD<break/>SG3 (<italic toggle="yes">n</italic> = 8): 14 days BR</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No systematic difference between the SGs.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Austermann et al., 2021 [<xref rid="B63-ijms-23-08650" ref-type="bibr">63</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 males (3 ± 8 years)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 10): 60 days HDBR + antioxidant<break/>CG (<italic toggle="yes">n</italic> = 10): 60 days HDBR </td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant supplement had no effect on bone resorption or formation.</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated</bold>
                      <bold>microgravity in animals</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cabahug-Zuckerman et al., 2016 [<xref rid="B52-ijms-23-08650" ref-type="bibr">52</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 C57BL/6J male mice (4 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 6): 14 days HLU<break/>SG2 (<italic toggle="yes">n</italic> = 6): 14 days HLU + PC-I<break/>SG3 (<italic toggle="yes">n</italic> = 6): PC-I<break/>CG (<italic toggle="yes">n</italic> = 6): no intervention</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The PC-I used in SG2 prevented the HLU-induced increase in osteocyte apoptosis, osteocyte RANKL expression, and endocortical resorption in both cortical and trabecular bone compared to SG1.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Colaianni et al., 2017 [<xref rid="B64-ijms-23-08650" ref-type="bibr">64</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 C57BL6 male mice (2 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU + R-irisin<break/>SG2 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU<break/>SG3 (<italic toggle="yes">n</italic> = 8): R-irisin<break/>CG (<italic toggle="yes">n</italic> = 8): vehicle injection </td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG: R-irisin prevented loss of cortical or trabecular BMD in SG1. R-irisin induced the recovery of bone mass through attenuation of osteoprotegerin; thus, the RANKL/osteoprotegerin ratio was the same in SG1 as CG. R-irisin also inhibited the decrease in <italic toggle="yes">ALP</italic> and <italic toggle="yes">Collα1</italic> mRNA expression caused by simulated microgravity in SG1. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ding et al., 2021 [<xref rid="B65-ijms-23-08650" ref-type="bibr">65</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 C57BL/6J male mice (12 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 6): 28 days HLU + alendronate<break/>SG2 (<italic toggle="yes">n</italic> = 6): 28 days HLU + raloxifene<break/>SG3 (<italic toggle="yes">n</italic> = 6): 28 days HLU + teriparatide<break/>SG4 (<italic toggle="yes">n</italic> = 6): 28 days HLU + Anti-RANKL<break/>SG5 (<italic toggle="yes">n</italic> = 6): 28 days HLU + bortezomib<break/>CG1 (<italic toggle="yes">n</italic> = 6): normal gravity<break/>CG2 (<italic toggle="yes">n</italic> = 6): 28 days HLU</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 and SG4 reduced urinary C-telopeptide of type I collagen compared to CG2 (<italic toggle="yes">p</italic> &lt; 0.05) and restored BMD close to CG1. <break/>SG5 reduced urinary C-telopeptide of type I collagen (<italic toggle="yes">p</italic> &lt; 0.05) and enhanced P1NP compared to CG2 (<italic toggle="yes">p</italic> &lt; 0.05), which increased BMD and strength compared to CG2 (<italic toggle="yes">p</italic> &lt; 0.05).<break/>SG2 had no effect on bone loss. <break/>SG3 only stimulated cortical bone formation.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Han et al., 2018 [<xref rid="B66-ijms-23-08650" ref-type="bibr">66</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48 WTC57BL/6J mice (2–3 months)<break/>32 KOC mice (2–3 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 16): 4 weeks HLU + CDL <break/>SG2 (<italic toggle="yes">n</italic> = 16): 4 weeks HLU + KOC<break/>SG3 (<italic toggle="yes">n</italic> = 16): 4 weeks HLU + CDL + KOC<break/>CG1 (<italic toggle="yes">n</italic> = 16): 4 weeks HLU<break/>CG2 (<italic toggle="yes">n</italic> = 16): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased BV/TV, trabecular number and thickness, ALP activity, osteocalcin content, and mRNA level of <italic toggle="yes">bone morphogenetic protein-2</italic>, <italic toggle="yes">Collα1</italic>, <italic toggle="yes">ALP</italic>, and <italic toggle="yes">osteocalcin</italic> in SG1 compared to CG1, but this effect was even bigger in SG3 with combined CDL and KOC. Osteoprotegerin increased, while RANKL level decreased in SG3 compared to CG1; however, in SG1, only osteoprotegerin increased compared to CG1.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DeLong et al., 2020 [<xref rid="B67-ijms-23-08650" ref-type="bibr">67</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 C57BL/6J male mice (16 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 15): 3 weeks HLU + TC<break/>CG1 (<italic toggle="yes">n</italic> = 10): 3 weeks HLU<break/>CG2 (<italic toggle="yes">n</italic> = 10): 3 weeks TC</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In SG, a 2% loss in cortical thickness and 15% loss in trabecular BV/TV was observed compared to 6% and 50% corresponding losses in CG1. This protective effect did not influence the cortical bone at lower strained distal shaft. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yang et al., 2021 [<xref rid="B68-ijms-23-08650" ref-type="bibr">68</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36 C57BL/6J male mice (8 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 6): 4 weeks HLU + SMF<break/>CG1 (<italic toggle="yes">n</italic> = 6): 4 weeks GMF<break/>CG2 (<italic toggle="yes">n</italic> = 6): 4 weeks SMF<break/>CG3 (<italic toggle="yes">n</italic> = 6): 4 weeks HLU<break/>CG4 (<italic toggle="yes">n</italic> = 6): 4 weeks HLU + GMF</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG had an increased BV/TV, trabecular number, connectivity density, cortical area, and femoral bone mineral content compared to CG4 (<italic toggle="yes">p</italic> &lt; 0.05). Additionally, TRAP5 decreased during SMF compared to CG4 (<italic toggle="yes">p</italic> &lt; 0.05).</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xu et al., 2022 [<xref rid="B69-ijms-23-08650" ref-type="bibr">69</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 C57BL/6 male mice (8 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG (<italic toggle="yes">n</italic> = 6): 4 weeks HLU + CEFFE<break/>CG1 (<italic toggle="yes">n</italic> = 6): normal gravity<break/>CG2 (<italic toggle="yes">n</italic> = 6): 4 weeks HLU + PBS</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG2: CEFFE in SG increased BV/TV and trabecular number and cortical thickness. Additionally, the number of empty lacunae was reduced by CEFFE. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xiao et al., 2021 [<xref rid="B70-ijms-23-08650" ref-type="bibr">70</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 C57BL/6J male mice (6 months)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 10): 28 dats HLU + CMS<break/>SG2 (<italic toggle="yes">n</italic> = 10): 28 dats HLU + STE<break/>CG1 (<italic toggle="yes">n</italic> = 10): normal gravity + PBS<break/>CG2 (<italic toggle="yes">n</italic> = 10): 28 days HLU + PBS</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG2: CMS increased the BMD, BV/TV, cortical thickness, and trabecular thickness and number. CMS decreased trabecular spacing, number of OCs per field, and percentage of OC surface per bone surface. STE only increased BV/TV, as well as trabecular thickness and number, and decreased trabecular spacing.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wakabayashi et al., 2020 [<xref rid="B71-ijms-23-08650" ref-type="bibr">71</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 ddY male mice (8 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU + IL-6 mAb<break/>SG2 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU + alendronate<break/>CG1 (<italic toggle="yes">n</italic> = 8): normal gravity + vehicle<break/>CG2 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU + vehicle</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG2: IL-6 mAb in SG1 reduced number of OCs per bone perimeter compared to CG2 (<italic toggle="yes">p</italic> &lt; 0.05). Alendronate in SG2 increased BV/TV and trabecular number, while decreasing number of OCs per bone perimeter in both femur and tibia (<italic toggle="yes">p</italic> &lt; 0.05). </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diao et al., 2018 [<xref rid="B72-ijms-23-08650" ref-type="bibr">72</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 SD male rats (6 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 30): 30 days HLU + polyphenol<break/>SG2 (<italic toggle="yes">n</italic> = 10): 30 days HLU<break/>CG (<italic toggle="yes">n</italic> = 10): normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 compared to SG2: SG1 alleviated the rise of bone surface/bone volume ratio and decreased ME, BMD, and BV/TV, but it differed from CG. SG1 increased ALP, P1NP, and expression of <italic toggle="yes">RUNX2</italic>, <italic toggle="yes">Collα1</italic>, <italic toggle="yes">ALP</italic>, <italic toggle="yes">osteonectin</italic>, <italic toggle="yes">osterix</italic>, <italic toggle="yes">osteocalcin</italic>, and <italic toggle="yes">β-catenin</italic>.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">He et al., 2020 [<xref rid="B73-ijms-23-08650" ref-type="bibr">73</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 C57BL/6J male mice (10 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU<break/>SG2 (<italic toggle="yes">n</italic> = 8): 4 weeks HLU + IL-6 mAb<break/>CG1 (<italic toggle="yes">n</italic> = 8): normal gravity<break/>CG2 (<italic toggle="yes">n</italic> = 8): normal gravity + IL-6 mAb</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased BMD, BV/TV, trabecular thickness, trabecular number, stiffness, and ultimate load in femur in SG2 compared to SG1 (<italic toggle="yes">p</italic> &lt; 0.05). Serum osteocalcin and mRNA expression of <italic toggle="yes">ALP</italic>, <italic toggle="yes">osteocalcin</italic> and <italic toggle="yes">TRAP5</italic> increased, while RANKL/osteoprotegerin ratio decreased in SG2 compared to SG1 (<italic toggle="yes">p</italic> &lt; 0.05). All these factors were normalized compared to CG1.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Khajuria et al., 2015 [<xref rid="B74-ijms-23-08650" ref-type="bibr">74</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 male Wistar rats (12 weeks)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1 (<italic toggle="yes">n</italic> = 6): 20 weeks RHLI <break/>SG2 (<italic toggle="yes">n</italic> = 6): 10 weeks RHLI+ 10 weeks RHLI/ZOL<break/>SG3 (<italic toggle="yes">n</italic> = 6): 10 weeks RHLI+ 10 weeks RHLI/ALF<break/>SG4 (<italic toggle="yes">n</italic> = 6): 10 weeks RHLI+ 10 weeks RHLI/ALF/ZOL<break/>CG (<italic toggle="yes">n</italic> = 6): nonimmobilized control</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The combination of ZOL + ALF was more effective in decreasing bone porosity, in improving the mechanical strength of the femoral midshaft, and in improving dry bone and ash weights than the respective monotherapies.</td>
                  </tr>
                  <tr>
                    <td colspan="4" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">
                      <bold>Simulated</bold>
                      <bold>microgravity in vitro</bold>
                    </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cristofaro et al., 2019 [<xref rid="B59-ijms-23-08650" ref-type="bibr">59</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human bMSCs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 88 h RPM + SCHN<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCHN had a promoting effect in SG on the deposition of hydroxyapatite crystals compared to CG (<italic toggle="yes">p</italic> &lt; 0.05).</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Braveboy-Wagner et al., 2022 [<xref rid="B75-ijms-23-08650" ref-type="bibr">75</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7F2 murine OBs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG: 6 days RPM + nutraceuticals (curcumin, carnosic acid, and zinc)<break/>CG: 6 days RPM</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compared to CG: In SG, ALP activity was elevated 160% by 50 µm zinc, 140% by 7.5 µm curcumin, and 113% by 10 µm carsonic acid. SG had an induced expression of <italic toggle="yes">ALP</italic>, <italic toggle="yes">RUNX2,</italic> and <italic toggle="yes">osteonectin</italic> in nonosteogenic maintenance medium. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chen et al., 2020 [<xref rid="B76-ijms-23-08650" ref-type="bibr">76</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine primary OBs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 48 h RPM + R-irisin<break/>SG2: 48 h RPM<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower doses of R-irisin promote both expression of <italic toggle="yes">Collα1</italic> and <italic toggle="yes">ALP</italic> (<italic toggle="yes">p</italic> &lt; 0.05), activity of ALP, and calcium deposition in OBs. R-irisin also recovered the microgravity-induced reduction of <italic toggle="yes">ALP</italic> and <italic toggle="yes">Collα1</italic> (<italic toggle="yes">p</italic> &lt; 0.001), ALP activity, and β-catenin expression.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethiraj et al., 2020 [<xref rid="B77-ijms-23-08650" ref-type="bibr">77</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RAW264.7 pre-OCs</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 24 h RCCS + MG-132<break/>SG2: 24 h RCCS <break/>CG1: normal gravity<break/>CG2: normal gravity + MG-132</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The proteasome inhibitor MG-132 in SG1 suppressed receptor activator of nuclear factor κβ receptor expression, compared to CG.<break/>MG-132 treatment in SG1 also showed a significant decrease in resorbed bone area compared to SG2. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diao et al., 2018 [<xref rid="B72-ijms-23-08650" ref-type="bibr">72</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OBs from newborn rat</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 72 h RPM + polyphenols<break/>SG2: 72 h RPM<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyphenols promoted ALP activity in SG1 compared to SG2 (<italic toggle="yes">p</italic> &lt; 0.01). Polyphenols had a dose–effect response, but were still decreased compared to CG (<italic toggle="yes">p</italic> &lt; 0.05).</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">He et al., 2020 [<xref rid="B73-ijms-23-08650" ref-type="bibr">73</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Murine pre-OB cell line MC3T3-E1 </td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 96 h RB<break/>SG2: 96 h RB + IL-6 mAb<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 mAb increased ALP activity, osteoprotegerin level, and mRNA expression of <italic toggle="yes">ALP</italic>, <italic toggle="yes">osteopontin</italic> and <italic toggle="yes">RUNX2</italic>, while RANKL decreased in SG2 compared to SG1 (<italic toggle="yes">p</italic> &lt; 0.05). All these factors were normalized compared to CG.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">He et al., 2020 [<xref rid="B73-ijms-23-08650" ref-type="bibr">73</xref>]</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macrophage cell line RAW264.7</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SG1: 96 h RB<break/>SG2: 96 h RB + IL-6 mAb<break/>CG: normal gravity</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 mAb decreased mRNA expression of cathepsin K and TRAP5 in SG2 compared to SG1 (<italic toggle="yes">p</italic> &lt; 0.05). All these factors were normalized compared to CG.</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Abbreviations: OC: osteoclast, OB: osteoblast, EC: endothelial cell, SG: study group, ISS: International Space Station, R-irisin: recombinant irisin, CG: control group, RUNX2: RUNX family transcription factor 2, Collα1: collagen type 1 α-1, bMSC: bone mesenchymal stem cell, SCHN: strontium-containing hydroxypatitie nanoparticles, ALP: alkaline phosphatase, <italic toggle="yes">n</italic>: number of individuals, HDBR: head-down tilt bed rest, LE: locomotor exercise, BMD; bone mineral density, BR: bed rest, RE: resistive exercise, PBD: pulse-based diet, CD: cognitive training, and diet protein and alkaline, HLU: hindlimb-unloading, PC-I: pan-caspase inhibitor, RANKL: receptor activator of nuclear factor κβ ligand, P1NP: N-terminal propeptide of type 1 procollagen, KOC: knockout casein kinase 2-interacting protein-1, CDL: constrained dynamic loading, BV/TV: bone volume fraction, TC: tibial compression, SMF: static magnetic field, GMF: geomagnetic field, TRAP5: tartrate-resistant acid phosphatase 5b, CEFFE: cell-free fat extract, PBS: phosphate-buffered saline, CMS: cyclic mechanical stretch treated bMSCs-derived exosomes, STE: static cultured bMSCs-derived exosomes, IL-6 mAb: interleukin-6 monoclonal antibody, ME: mechanical properties, RPM: random positioning machine, RCCS: rotary cell culture system, RB: rotary wall vessel bioreactor, RHLI: right hindlimb immobilization, ALF: alfacalcidol, ZOL: zoledronic acid.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <table-wrap position="float" id="ijms-23-08650-t003">
              <object-id pub-id-type="pii">ijms-23-08650-t003_Table 3</object-id>
              <label>Table 3</label>
              <caption>
                <p>An overview of a selection of the latest clinical trials of µ<italic toggle="yes">g</italic>-induced BL and countermeasures.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Title and Identification Number</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Subjects</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Design</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Outcome</th>
                    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Status/Conclusion</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Effects of Whole Body Unloading on Physiological Function (NCT03195348)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV SG</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate the effects of hyper-buoyancy flotation in 7 days on skeletal muscles and bone mineral density.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Completed. No results posted yet.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A New Nutritional Countermeasure to Prevent the Deconditioning Induced by 60 Days of Antiorthostatic Bed Rest (NCT03594799)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV RP<break/>Investigator masking</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate if XXS-2A-BR2 prevents or reduces the harmful effects caused by physical inactivity through 60 days of bed rest. Secondary outcome is the change in urinary C-telopeptide of type I collagen.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Completed. No effect on urinary C-telopeptide of type I collagen, serum β-C-telopeptide of type I collagen, NTX, alkaline phosphatase, P1NP, or osteocalcin.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thigh Cuffs to Prevent the Deconditioning Induced by 5 Days of Dry Immersion (NCT03915457)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV RP<break/>No masking</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate if thigh cuffs prevent or reduce the deconditioning caused by dry immersion. The outcome is the change in the balance of bone remodeling markers.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Completed. No results posted yet.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Planetary Habitat Simulation: Bone Metabolism Studies (NCT02637921)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV RC<break/>Open-label masking</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate the effect of hypoxia and bed rest on bone metabolism. Outcomes include the change in markers of bone cell activity.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Completed. Serum calcium and NTX increased, while P1NP decreased. No difference between normoxia or hypoxia. </td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Understanding the Negative Effects of Bed Rest and Using Exercise as Countermeasure (NCT04964999)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV RP<break/>Open-label masking</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate if exercise counteracts the negative effects caused by 2 week head-down tilt bed rest on bone markers among others.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recruiting.</td>
                  </tr>
                  <tr>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Integrative Study of Physiological Changes Induced by a 5-Day Dry Immersion on 20 Healthy Female Volunteers (NCT05043974)</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV SG<break/>Open-label masking</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigate the changes caused by dry immersion for 5 days in female physiology. The outcome is the change in bone metabolism and bone mineral density.</td>
                    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recruiting.</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Abbreviations: NCT: national clinical trial, IV: interventional, SG: single-group assignment, RP: randomized parallel assignment, NTX: urinary N-telopeptide of type I collagen, P1NP: N-terminal propeptide of type 1 procollagen, RC: randomized crossover assignment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
